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Summary 
 
Purpose of this study: To evaluate the impact kilovoltage imaging, a new imaging technology 
at our department, has had on the treatment of our patients and to determine the preferred 
imaging modality and treatment machine for different situations. Additionally, based on a 
retrospective evaluation of the alignment data for two different patient populations, set-up 
errors for individual patients and for the two populations, as well as adequate treatment 
margins are calculated.  
Methods and materials: Three different linacs, the Siemens Arstiste ART1 and ART 2 and the 
Siemens Oncor ONC2, each offering different imaging modalities for IGRT, were used. The 
ART1 is equipped with the best imaging technique, kilovoltage imaging. The data from 89 
patients, 36 prostate cancer and 53 head-and-neck cancer patients, receiving IGRT between 
January 2013 and December 2013, was analyzed. A total of 3061 radiation fractions and 
1260 set-up images were retrospectively evaluated. Set-up errors were calculated for three 
dimensions (superior-inferior (S-I), left-right (L-R)  and anterior-posterior (A-P)) based on the 
alignment data from the couch shifts performed, in order to account for set-up variation 
detected in the verification imaging prior to treatment delivery. CTV-PTV margins were 
calculated applying the set-up errors to common margin recipes: 2∑+0.7σ (Stroom et al., 
1999) and 2.5∑+0.7σ (van Herk et al., 2000). 
Results:  Linac employment statistics: The preferred treatment machine for head-and-neck 
cancer treatment was the linac ART2 (56%) followed by the ART1 (31%) and the ONC2 (13%). 
Prostate cancer patients were treated mostly at the ART1 (44%) and the ONC2 (37%). The 
ART2 was used the least (19%). Planar imaging was used more frequently than CBCT 
imaging. The frequency of CBCT imaging was higher for prostate cancer patients in 
comparison to head-and-neck cancer patients. At the ART1 the best imaging modality, kV 
imaging, was not always used. Especially when treating head-and-neck cancer IBL planar 
images were often preferred.  Set-up errors and margins:  Systematic set-up errors (µ) for 
the individual head-and-neck cancer patients range mainly from -0.15 to 0.2 cm (S-I), -0.1 to 
0.3 cm (L-R) and -0.1 cm to 0.1 cm (A-P) and for the individual prostate cancer patients from 
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-0.4 to 0.25 cm (S-I), -0.3 to 0.1 cm (L-R) and -0.3 to 0.2 cm (A-P). Random errors (r) for 
individual head-and-neck cancer patients range from 0.06 to 0.43 cm (S-I), 0.07 to 0.48 cm 
(L-R) and 0.09 to 0.40 cm (A-P) and for individual prostate cancer patients from 0.15 to 0.72 
cm (S-I), 0.21 to 0.83 cm (L-R) and 0.11 to 0.51 cm (A-P). The population systematic set-up 
error (M) for both populations is approximately zero; in all three directions values are 
smaller than 1 mm. The variation of the population systematic error (∑Ϳ is larger for prostate 
cancer patients with values of 0.16 cm (S-I), 0.18 cm (L-R), and 0.17 cm (A-P) in comparison 
to 0.10 cm in all three directions for head-and-neck cancer patients. The population random 
error (σ) for head-and-neck cancer patients is 0.19 cm (L-R and A-P) and 0.22 cm (S-I) and for 
prostate cancer patients 0.37 cm (S-I), 0.49 cm (L-R) and 0.35 cm (A-P). No clear differences 
are found in the calculation of set-up errors when using the data from the different imaging 
modalities separately. The calculated margins for head-and-neck cancer patients are 0.35 cm 
(S-I) and 0.33 cm (L-R and A-P) according to Stroom et al. (1999) or 0.4 cm (S-I) and 0.38 cm 
(L-R and A-P) according to van Herk et al. (2000) and for prostate cancer patients  0.57 cm (S-
I), 0.70 cm (L-R) and 0.58 cm (A-P) according to Stroom et al. (1999) and 0.66 cm (S-I) 0.79 
cm (L-R)  and  0.67 cm (A-P) according to van Herk et al. (2000). 
Conclusion: The study shows that at our department anatomic differences are taken into 
account when choosing the different linacs and imaging techniques. Generally, for IGRT 
better imaging is used for patients with larger set-up errors. However, the study has also 
revealed that especially at the linac ART1 there is still room for improvement. As shown, 
prostate cancer patients are subject to much greater geometric variability in comparison to 
head-and-neck cancer patients. The random population set-up errors (σ) are larger for 
prostate cancer in comparison to head-and-neck cancer patients. The study has 
demonstrated that there is practically no systematic set-up error (M) for either patient 
population. Therefore, the quality assurance measures in our clinic are shown to be 
successful. Additionally, this study has revealed that the choice of imaging modality used for 
IGRT does not have a clear effect on the calculation of set-up errors. According to the margin 
recipes presented by van Herk (2000) and Stroom et al. (1999) the CTV-PTV margins applied 
in our clinic for prostate and head-and-neck cancer patients are sufficient. 
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Zusammenfassung 
Zielsetzung: Evaluierung der Auswirkungen einer neuen Kilovolt-Bildgebungstechnologie für 
IGRT in unserer Klinik und Ermittlung der bevorzugten Bildgebungsmethode und 
Bestrahlungsmaschine für verschiedene Situationen. Berechnung von systematischen und 
randomisierten Lage-Fehlern in der Positionierung von einzelnen Patienten und Patienten 
Populationen anhand einer retrospektiven Auswertung der Verschiebungsdaten der 
Bestrahlungs-Liege, sowie Berechnung der adäquaten CTV-PTV Expansion. 
Methoden und Materialien: Drei verschiedene Bestrahlungs-linacs (Siemens Artiste ART1 
und ART2, Siemens Oncor ONC2) mit unterschiedlichen Bildgebungstechnologien für IGRT 
wurden verwendet. Ausgestattet mit Kilovolt Energie für die Bildgebung liefert der 
Beschleuniger linac ART1 die beste Bildqualität. Die Daten von 89 Patienten, 36 
Prostatakrebs und 53 HNO-Krebs Patienten, welche zwischen Januar und Dezember 2013 
Bestrahlung erhielten, wurden analysiert. Insgesamt 3061 Bestrahlungsfraktionen und 1260 
Bildgebungen wurden retrospektiv evaluiert. Anhand der Daten der einzelnen 
Verschiebungen der Bestrahlung-Liege nach Bildgebung wurden Lage-Fehler (set-up error) in 
drei Dimensionen berechnet (superior-inferior (S-I), links-rechts (L-R)  und anterior-posterior 
(A-P)Ϳ.  Die Fehler ǁurdeŶ ǀerǁeŶdet uŵ „CTV-PTV-ŵarigŶs͞ aŶhaŶd herköŵŵliĐher 
Formeln, 2∑+0.7σ (Stroom et al., 1999) und 2.5∑+0.7σ (van Herk et al., 2000), zu berechnen. 
Ergebnisse: Linac-Anwendungsstatistik: Der bevorzugte Beschleuniger für HNO Patienten 
war der linac ART2 (56%), gefolgt von dem ART1 (31%) und dem ONC2 (13%). Prostata 
Patienten wurden meist am ART1 (44%) und am ONC2 bestrahlt; der ART2 wurde nur selten 
verwendet (19%). 2D Achsen Aufnahmen wurden häufiger als 3D CBCT Aufnahmen 
verwendet, jedoch erhielten im Vergleich Prostata Patienten deutlich häufiger CBCT 
Aufnahmen als HNO Patienten. Nicht immer wurde am ART1 die Energie für die beste 
Bildqualität, Kilovolt, für die Bildgebung verwendet. Insbesondere für HNO Patienten wurden 
häufig IBL Achsen Aufnahmen bevorzugt. „“et-up͞ Fehler uŶd „CTV-PTV Expansion͞: 
Systematische Fehler (µ) für einzelne HNO-Patienten lagen zwischen -0.15 cm und 0.2 cm (S-
I), -0.1 cm und  0.3 cm (L-R), sowie -0.1 cm und 0.1 cm (A-P), für einzelne Prostata Patienten 
zwischen -0.4 cm und 0.25 cm (S-I), -0.3 cm und 0.1 cm (L-R), sowie -0.3 cm und 0.2 cm (A-P). 
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Zufällige Fehler (r) für einzelne HNO-Patienten lagen zwischen 0.06 cm und 0.43 cm (S-I), 
0.07 cm und 0.48 cm (L-R), sowie 0.09 cm und 0.40 cm (A-P) und für einzelne Prostata 
Patienten zwischen 0.15 cm und 0.72 cm (S-I), 0.21 cm und 0.83 cm (L-R), sowie 0.11 cm und 
0.51 cm (A-P). Der systematische Fehler für die gesamte Population (M) für sowohl HNO, als 
auch Prostata Patienten beträgt nahezu Null, mit weniger als 1 mm in allen drei 
Dimensionen. Mit 0.16 cm (S-I), 0.18 cm (L-R), und 0.17 cm (A-P) ist die Variation des 
systematischen Fehlers für die gesamte Population (∑Ϳ größer für Prostata PatieŶteŶ iŵ 
Vergleich zu HNO-Patienten (0.10 cm in alle drei Richtungen). Der randomisierte Fehler für 
die gesaŵte PopulatioŶ ;σͿ für HNO-Patienten beträgt 0.19 cm (L-R und A-P) und 0.22 cm (S-
I) und für Prostata Patienten 0.37 cm (S-I), 0.49 cm (L-R) und 0.35 cm (A-P). In der 
Berechnung der verschieden „set-up͞ Fehler unter gesonderter Anwendung der Daten der 
unterschiedlichen Bildgebungsmodalitäten konnten keine Unterschiede festgestellt werden. 
Die ďereĐhŶete ͞CTV-PTV Expansion͟ für HNO Patienten liegen bei 0.35 cm (S-I) und 0.33 cm 
(L-R und A-P) nach Stroom et al. (1999) oder  0.4 cm (S-I) und 0.38 cm (L-R und A-P) nach  
van Herk  (2004) und für Prostata Patienten bei  0.57 cm (S-I), 0.70 cm (L-R) und 0.58 cm (A-
P) nach Stroom et al. (1999) oder 0.66 cm (S-I) 0.79 cm (L-R)  und  0.67 cm (A-P) nach van 
Herk et al. (2000). 
Schlussfolgerung: In unserer Klinik werden die anatomischen Unterschiede der 
verschiedenen Patienten-Populationen in der Auswahl des Bestrahlungsgerätes und der 
Auswahl der Bildgebungsmodalität berücksichtigt. Generell werden für Patienten mit 
größeren Lage-Fehlern bessere Bildgebungen verwendet, am linac ART1 ist diesbezüglich 
jedoch eine Verbesserung noch möglich. Im Vergleich zu HNO Patienten unterliegt das 
Zielvolumen bei Prostata Patienten einer viel größeren geometrischen Variabilität. Die 
randomisierten Populations-Fehler (σ) für Prostata Patienten sind größer im Vergleich zu 
HNO Patienten. Weiterhin hat diese Studie gezeigt, dass für beide Populationen praktisch 
kein systematischer Lage-Fehler (M) nachgewiesen werden kann, folglich sind die 
Qualitätssicherungsmethoden in unserer Klinik suffizient. Die Studie hat weiterhin gezeigt, 
dass die Wahl der Bildgebungsmodalität keinen Einfluss auf die Größe der Lage-Fehler hat. 
Nach den Berechnungsformeln von van Herk et al. (2000) und Stroom et al. (1999) ist die in 
unserer Klinik angewandteŶ „CTV-PTV Expansion͞ aŶgeŵesseŶ. 
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1. Introduction  
 
Radiation therapy is a key element in the treatment of cancer patients. It has the potential to 
control tumor progression and improve survival. It can also increase the quality of life of 
cancer patients, reducing pain or other symptoms. Radiation oncology is constantly 
undergoing changes due to rapid advances in technology and better understanding of 
human molecular biology. This has led to many improvements in achieving the main goal of 
radiation therapy:  To eliminate or control malignant cells while sparing healthy tissue.  
 
1.1 Conformal radiation therapy 
Conformal irradiation techniques like three-dimensional conformal radiation therapy 
(3DCRT) and intensity-modulated radiation therapy (IMRT), made possible by improved CT 
based planning systems and advances in planning software and computer-controlled 
radiation delivery, have become standard methods in external beam radiation therapy. 
These conformal radiation techniques allow an extremely accurate application of external 
beam radiation, using specialized software during treatment planning to precisely conform 
the radiation dose distribution to the shape of the tumor volume. This allows sparing of the 
surrounding normal tissues aŶd orgaŶs at risk ;OAR’sͿ, therefore, limiting the toxicity 
delivered to healthy tissue (Koper et al., 1999; Nutting et al., 2000; Pirzkall et al., 2000; 
Dawson et al., 2006; Nutting et al., 2011). 
Conformal radiation therapy is associated with sharp dose gradients between the edges of 
the target volume and the surrounding healthy tissue.  This is due to the precise conformity 
of the dose delivered to the tumor and the fast drop off of the dose outside the tumor 
volume. In general, the consequences of geometrical errors are more severe due to the 
sharp dose gradients in conformal radiation therapy since even small geometric variations 
may lead to a geometric miss, increasing the chances of toxicity to the surrounding organs at 
risk ;OAR’sͿ and the risk of underdosage of the target volume (Chen et al., 2011). This further 
increases the importance of accurately delivering the radiation dose to the defined target 
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volume. Ideally, the position and anatomy of the patient during the daily treatments should 
be equivalent to the setting at the time of treatment planning. To compensate for inevitable 
geoŵetriĐal uŶĐertaiŶties iŶ the dailǇ positioŶiŶg of the patieŶt a ͞safetǇ͟ ŵargiŶ is added to 
the target volume for treatment (Dawson et al., 2006, Korreman et al., 2010).  
 
1.2 Target volume  
According to the International Commission on Radiation Units and Measurements (ICRU), 
different volumes are classified as followed: The macroscopic volume of the tumor is 
identified as the GTV, the gross tumor volume. It can be determined by clinical examination 
or different imaging technics. The GTV is further extended to regions which contain the 
suspected subclinical microscopic malignant tumor growth. This volume is defined as the 
CTV, the clinical target volume. It may consist of the GTV plus a margin or it may additionally 
include lymph nodes. To reach the goal of the radiation therapy, the CTV needs to be treated 
adequately.  The CTV is an anatomical-clinical concept, it has to be defined before a choice 
of treatment modality and technique is made. The third volume defined by the ICRU Report 
50 is the PTV, the planning target volume. The PTV is a geometrical concept defined in order 
to select the appropriate radiation technique (field sizes and beam arrangements). To 
determine the PTV a margin is added to the CTV. It includes all the possible geometrical 
variations and inaccuracies, such as organ motion, patient motion and set-up error. Defining 
the PTV is important to ensure that the prescribed radiation dose is actually delivered to the 
CTV.  AdditioŶallǇ the OAR’s, the orgaŶs at risk, are deliŶeated. OAR’s are ĐoŶsidered as the 
organs in the radiation field that are especially sensitive to the radiation toxins and therefore 
need to be spared. In Figure 1 these volumes are shown in a schematic illustration. (ICRU-
Report 50, 1993; ICRU-Report 62, 1999) 
Figure 1: schematic illustration of the volumes for treatment planning defined by the ICRU  
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1.3 Image-guided Radiotherapy (IGRT) 
Because the precise delivery of radiation is of such great importance when using conformal 
radiation techniques, the interest and importance of image guided radiation therapy (IGRT) 
is steadily increasing in the radiation oncology field. The term image-guided radiotherapy 
(IGRT), generally speaking, refers to any implementation of imaging techniques in radiation 
therapy in order to improve the quality of treatment. Since the advent of IGRT the available 
imaging techniques are constantly being further developed and improved. For target 
delineation during treatment planning the planning CT is often additionally fused with other 
imaging techniques, such as MRI and PET, for better tumor localization (Dawson et al., 2006). 
Imaging techniques, however, are not only used during treatment planning, but also during 
the delivery of the radiation treatment itself. During the actual delivery of the radiation 
treatment imaging techniques are usually used as a method of quality assurance to improve 
the geometrical accuracy of the delivered dose. The term IGRT, therefore, most often refers 
to the imaging obtained directly before the actual treatment delivery. Frequent set-up 
verification images are obtained over the course of the radiation treatment in order to 
localize the target volume and guide the administration of the radiation accordingly. Set-up 
errors and other geometrical errors are registered and corrected, either by altering the 
patieŶt’s posture or the positioŶ of the treatŵeŶt ĐouĐh, or ďǇ adaptiŶg the treatŵeŶt plaŶ 
to the geometrical changes occurring during the course of radiation treatment. This enables 
a more precise delivery of the intended radiation dose to the target volume (Mackie et al., 
2003; Dawson et al., 2006; Verellen et al., 2008; Korremann et al., 2010). Because of its 
ability to identify, evaluate and reduce interfraction set-up errors (errors occurring within 
different radiation fractions) and detect intrafraction target motion (changes of the target 
volume within the same radiation fraction)  image-guided radiotherapy (IGRT) is 
incorporated in more and more clinical trials (Ghilezan et al., 2004; Letourneau et al., 2005; 
Li et al., 2008).  
The increased accuracy achieved through the implementation of conformal radiation 
techniques in cooperation with in-room imaging techniques has allowed a reduction of 
͞safetǇ͟ ŵargiŶs ;BeltraŶ et al., 2008). On the one hand, this has been shown to improve 
sparing of normal tissues and to minimize toxicity. A typical example of this is found in the 
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treatment of head-and-neck cancer where the reduced toxicity to the parotic glands has 
been proven to reduce the incidence of xerostomia (dry mouth syndrome), thereby 
improving the quality of life (Pow et al., 2006; Wang et al., 2009). On the other hand the 
reduction of margins has allowed dose escalations in many cases. For example, in radiation 
therapy for prostate cancer this has led to an improvement of biochemical control rates and 
a decrease in rectal and bladder complications (Peeters et al., 2006, Kupelian et al., 2006, 
Pollack 2006, e.g.).  
 
1.4 Geometrical errors and their sources  
IŶ radiatioŶ therapǇ the terŵ ͞error͟ is used to desĐriďe the geoŵetriĐal ǀariaďilitǇ aŶd 
uncertainty encountered during radiation therapy. It does not refer to actually committed 
͞errors͟. Geometrical errors in radiation therapy may be introduced during treatment 
planning or at the delivery stage of radiation treatment. In both instances, there are 
numerous sources for geometrical errors limiting the accuracy of radiation therapy. 
Systematic errors are deviations which affect every radiation fraction in the same way. They 
are consistent over the course of treatment. They occur in the same direction and have a 
similar magnitude for each fraction throughout the treatment time, for each individual 
patient or for each patient population. They can be introduced during the acquisition of the 
planning CT during virtual simulation or during treatment planning and, therefore, are often 
referred to as ͞preparatioŶ͟ errors. Random errors are deviations that vary from fraction to 
fraction. Their magnitude and direction are different in each individually delivered treatment 
fraction. 
During treatment planning the tumor in the planning CT is imaged in an arbitrary position 
which may not be representative for the average position of the tumor and therefore may 
lead to a sǇsteŵatiĐ error. Also the ŵotioŶ of the patieŶt’s skiŶ relatiǀe to the iŶterŶal 
anatomy may lead to a systematic error (van Herk, 2004). The potentially largest source for 
systematic errors is the process of target delineation. The quality and resolution of the 
imaging technique used and the inter- and intra-observer variability in outlining the target, 
as well as the anatomic site of the tumor all have an impact on the magnitude of the 
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systematic error introduced during the delineation process. Other sources for systematic 
errors may be caused by errors in the calibration of the isocenter of treatment machines in 
respect to the isocenter of the planning CT scanner, by transfer errors created when 
transferring the data from the planning system to the treatment system or by other 
technical errors such as deviations of the room lasers. These errors, however, are usually 
minimal due to quality assurance methods (Korreman et al., 2010). 
Errors in the delivery stage of the radiation treatment are often caused by set-up variability. 
Set-up errors are iŶtroduĐed through geoŵetriĐ ǀariatioŶs of the patieŶt’s position and 
anatomy in relation to the conditions present during treatment planning. Factors that 
influence these set-up errors are, among others, positioning and immobilization methods, as 
well as the anatomic site treated. Immobilization methods aim at reducing this variability by 
iŶĐreasiŶg the reproduĐiďilitǇ of the patieŶt’s positioŶiŶg ;van Herk, 2004; Korremann et al., 
2010). 
Motion of the patient during treatment delivery, changes in the position of the tumor within 
the body due to organ motion, weight loss, breathing, bladder and rectum filling and 
changes in size and shape of the target volume due to deformation of the tumor throughout 
the course of radiation therapy are all factors causing geometric variations and therefore 
introducing errors - both systematic and random (van Herk, 2004).  
 
1.5 Set-up verification imaging 
The purpose of verification imaging is to identify and correct this geometrical variability 
during treatment delivery. Set-up verification images can be obtained before, during or after 
radiotherapy, they may be two-dimensional or three-dimensional. The main goal of 
obtaining verification images prior to treatment delivery is to detect set-up errors directly 
before treatment and enable an immediate correction. Deviations in the positioning of the 
patient, leading to a geometric variation of the target volume relative to the position of the 
target volume defined during treatment planning, can be registered and corrected. 
Evaluation of these set-up verification images retrospectively, after the delivery of the 
treatŵeŶt fraĐtioŶ, is referred to as ͞off-liŶe͟ ǀerifiĐatioŶ. Offline verification is a means of 
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eliminating systematic errors by evaluating and averaging the errors over several treatment 
fraĐtioŶs aŶd shiftiŶg the patieŶt’s positioŶ aĐĐordiŶglǇ. OffliŶe verification also offers the 
opportunity to adapt the treatment plan in cases of gross errors due to changes in shape and 
position of the target volume - this is referred to as ͞adaptiǀe plaŶŶiŶg͟ ;Bel et al., 1996; de 
Boer 2002Ϳ. IŶ ͞oŶ-liŶe͟ ǀerifiĐatioŶ the patieŶt’s set-up is evaluated and corrected directly 
prior to the delivery of the treatment fraction. Online verification with immediate correction 
via couch shifts is a means to correct not only systematic errors but also the random errors 
present in the respective treatment fraction (van Herk, 2004).  
 
1.6 Different Imaging techniques 
Electronic portal imaging and ultrasound image guidance have been some of the earliest 
imaging techniques used for IGRT. Since the interest in IGRT has steadily increased there is a 
constant development of new imaging techniques. Different in-room imaging techniques 
available are, among others, megavoltage imaging using the treatment beam line or, in some 
treatment machines, using an additionally added imaging beam line. Later, for reasons of 
better soft-tissue contrast and reduced extra imaging dose, kilovoltage x-ray imaging 
techniques were added. In the past years the development of imaging techniques has 
advanced from two-dimensional imaging techniques to volumetric three-dimensional 
imaging methods. These include megavoltage and kilovoltage cone beam CT systems and 
diagnostic CT scanners on rails (van Herk, 2007). With the rapid development in radiation 
oncology other advanced technologies for image-guided radiation therapy are also applied, 
for example electromagnetic localization, magnetic resonance imaging, fluoroscopy, 
tomosynthesis (Balter et al., 2007). 
 
1.7 Margin calculation  
As explained earlier the ICRU Report 50 and 62 recommend adding a „safetǇ͟ ŵargiŶ to the 
CTV in order to account for geometrical uncertainties, thereby defining the PTV. Since 
inappropriate definition of the CTV-PTV margin may result in underdosing of the CTV and/or 
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oǀerdosiŶg of the OAR’s, it is iŵportaŶt to Đhoose this ŵargiŶ ĐorreĐtlǇ. AĐĐordiŶg to the 
ICRU the margin should ensure that 99% of the CTV receives 95% of the prescribed dose. 
Several margin recipes combining uncertainties in order to calculate adequate CTV-PTV 
margins have been published (van Herk et al., 2000; Stroom et al., 1999) 
The ICRU-62 Report states that a linear addition of margins for set-up error and organ 
motion, a method suggested by the Nordic Association of Clinical Physics (NACP), is not 
recommended because the CTV-PTV margin would become too large and too much 
surrounding healthy tissue would be damaged. Instead the ICRU-62 Report suggests to 
quadratically add standard deviations for systematic and random errors in order to 
determine an overall standard deviation for margin calculation. (Aaltonen et al., 1997; ICRU-
62, 1999) 
However, as shown in Figure 2, geometrical uncertainties, classified into systematic and 
random errors, have different impacts on the dose distribution delivered during irradiation. 
Systematic errors affect all fractions in the same direction, leading to a shift of the dose 
distribution in respect to the CTV, whereas random errors point into different directions in 
each fraction and therefore lead to a blurring of the dose distribution. This explains why 
systematic errors have a much higher impact on the dose distribution than random errors. 
Figure 2: Schematic illustration showing the different effect of random and systematic errors 
 
Effect of errors 
Random errors blur the dose distribution around the CTV 
 
 
Systematic errors shift the dose distribution from the CTV 
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Stroom et al. (Stroom et al., 1999) and van Herk (van Herk et al., 2000), two different groups 
of researchers, have taken this into consideration and have presented us with margin recipes 
that account for the differences between systematic and random errors. Based on coverage 
probability Stroom et al. (1999) have presented the following margin to ensure that, on 
average, 99% of the target volume receives 95% of the prescribed dose or more: 
M=2∑+0.7σ 
(M = CTV-PTV Margin, ∑ = variation of the systematic setup error of a population, σ = 
random set-up error of a population) 
Van Herk et al. (2000) state, that the coverage probabilities do not account for very sharp 
tumor extensions. Based on dose population histograms van Herk et al. (2000) presented the 
following margin recipe which guarantees that 90% of patients in the population receive a 
minimum cumulative CTV dose of at least 95% of the prescribed dose: 
M=2.5∑+0.7σ 
(M = CTV-PTV Margin, ∑ =variation of the systematic setup error of a population, σ = 
random set-up error of a population 
As we can see the margin recipe by van Herk et al. (2000) leads to margins slightly larger 
than the recipe presented by Stroom et al. (1999). 
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1.8 Purpose of this study 
In November 2012 a diagnostic x-ray imaging modality (kVision) was added to one of our 
three treatment machines offering a new imaging technique with kilovoltage imaging. The 
kVision system from Siemens was tested for clinical practice at our clinic and a few other 
radiotherapy departments in Germany and was later incorporated into the clinical routine at 
our clinic after the end of the testing phase. After working with this additional kilovoltage 
imaging modality for more than a year our goal was to evaluate the impact this new imaging 
technology has had on the treatment of our patients. In this study we compare and analyze 
the implementation of the different imaging modalities and treatment machines available at 
our institution. Is there a change or trend visible after incorporating kilovoltage imaging into 
our daily routine? The employment of the different treatment machines and imaging 
modalities was investigated for different treatment situations. We evaluated the preferred 
imaging modality for different treatment situations and the frequency of imaging per 
treatment for the different machines and situations. Furthermore, the set-up variability for 
the different patient populations included in this study were analyzed. Random and 
systematic set-up errors were calculated and the effect of the different imaging modalities 
on these errors was evaluated. After determining the systematic and random errors we 
calculated margins according to the margin recipes presented by Stroom et al. (1999) and 
van Herk et al. (2000) in order to estimate appropriate CTV-PTV margins for different patient 
populations. 
This study concentrates on the data of two different patient populations. By selecting 
patients treated for head-and-neck cancer and patients treated for prostate cancer we chose 
two populations that have very different anatomic predispositions and are both very 
common tumors which are routinely treated with image-guided radiotherapy.  
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1.9 This study is organized as follows:  
After this general introduction on conformal radiation therapy, with an explanation of the 
target volume, the concept of IGRT with set-up verification imaging, the definition of 
geometric errors and the idea of margin calculation in order to establish sufficient CTV-PTV 
margins, the Methods and Materials used in order to realize this study are presented. 
In Methods and Materials the different treatment machines available in our clinic are 
introduced and their individual differences and qualities are discussed. Then the process of 
treatment planning, which entails the acquisition of a planning computed Tomography (CT), 
Target volume and CTV-PTV margin definition and the creation of the treatment plan as well 
as a description of the positioning standards used, is explained. Furthermore, additional 
details on systematic and random set-up errors as well as margin calculations are provided. 
Finally, in the last part of Methods and Materials, the two study populations included in this 
study are introduced.  
In the Results chapter, first of all, the statistics assessed for the employment of the different 
linacs within both patient populations are displayed. Then, the employment of the two 
different radiation techniques used for radiation of prostate cancer patients, 3DCRT versus 
IMRT, is compared.  Next, the analysis of the employment of the different imaging 
modalities used for both study populations over the course of time is presented. Afterwards, 
the data collected from the evaluation of the alignment data of the couch shifts for both 
population groups is shown and discussed. Also, the different systematic and random errors 
calculated for individual patients within the two populations and for the entire population 
are presented. Then, these values are applied to the margin recipes presented by Stroom et 
al. (1999) and van Herk et al. (2000) in order to establish adequate CTV-PTV margins for 
head-and-neck cancer and prostate cancer patients in our clinic. After presentation of each 
of these results a brief discussion and conclusion is offered before further discussing these 
results in the general Discussion chapter.  
Finally, a general conclusion that can be drawn from the results of this study is provided. 
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2. Methods and Materials 
 
2.1 Treatment machines 
At our clinic there are three different linear accelerators (linacs) available for external beam 
radiation, two Siemens Artiste (denominated ART1 and ART2), and one Siemens Oncor 
(denominated ONC2). All three linacs allow the delivery of intensity-modulated radiation 
therapy (IMRT) using 6MV matched energies. Additionally, the ART 1 and ONC2 are able to 
deliver 18MV matched radiation therapy.  All three treatment machines are capable of on-
board image-guided radiotherapy (IGRT) with different imaging techniques. For verification 
imaging all three linacs are able to obtain two dimensional orthogonal planar images and 
volumetric three-dimensional cone beam computer tomography (CBCT) images. The energy 
available for these images however is different for each treatment machine. All three linear 
accelerators are capable of generating images using the treatment beam line (TBL) with the 
lowest photon energy (6MV) available for radiation treatment. These 6MV treatment beam 
line images are low in soft tissue contrast and deliver a relatively high imaging dose 
compared to the standard diagnostic x-ray images. For better imaging quality the ART2 linac 
and the ART1 linac are additionally equipped with a dedicated imaging beam line (IBL) which 
allows the acquisition of images with a reduced photon energy of nominally 1MV and a 
higher soft-tissue contrast. The imaging beam line (IBL) is used exclusively for imaging 
purposes. The most advanced imaging technique available in our clinic is provided by the 
ART1 linac. The ART1 linac has the capability of generating kilovoltage (kV) images delivered 
by an additionally added diagnostic X-ray tube, mounted opposite to the treatment head. 
These kilovoltage (kV) images offer an even better image contrast while further reducing the 
imaging dose in comparison to the IBL images. The type of image modality used for 
verification imaging of the individual fractions was at the discretion of the radiation therapist 
and depended on the treatment machine used for the particular radiation fraction and other 
organizational factors such as time- and patient-capacity. However a general protocol with 
guidelines for imaging type and frequency is provided for each individual patient by the 
radiation oncologist. Figure 3 shows the ART1 linac during IBL imaging (1) and during kV 
imaging with the diagnostic X-ray tube opposite to the treatment head (2). Figure 4 shows 
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examples of planar images created with the three different imaging energies, 6MV, IBL 
(1MV) and kV for both head-and-neck cancer and prostate cancer patients. 
 
Figure 3: ART1 linac 1) during IBL imaging and 2) during KV imaging with the diagnostic X-ray tube 
opposite of the treatment head 
1)                                                                                     2) 
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Figure 4: Comparison of three planar set-up verification images taken with different imaging 
energies.  6MV, 1MV = IBL and kV for the example of a (1) head-and-neck cancer patient and a (2) 
prostate cancer patient 
1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) 
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2.2 Treatment planning  
2.2.1 Planning Computed Tomography (CT) 
Before commencing radiation treatment, all patients received a planning computerized 
tomography scan with a Philips BigBore 120kV CT-scanner. The patient was positioned on 
the CT couch by the radiation therapist in a comfortable and easily reproducible manner and 
immobilized. A thermoplastic mask, knee support or other equipment necessary for 
immobilization was fitted on the CT couch as required. With the help of room lasers, 
refereŶĐe poiŶts ǁere deterŵiŶed oŶ the patieŶt’s skiŶ or ŵask. These refereŶĐe poiŶts 
were marked with marking pens. A series of CT slices of the region of interest were taken 
and verified on screen. The CT reconstruction was transferred online to the Philips Pinnacle 
v.9.0-9.4 treatment planning system (TPS).  
 
2.2.2 Target volume and CTV-PTV margin definition 
Target delineation was conducted by the radiation oncologist on the CT slices by manually 
contouring the target volume and the organs at risk in agreement with the 
recommendations of the International Commission on Radiation Units and Measurements 
(ICRU) Report 50 (ICRU-50). IŶ order to aĐĐouŶt for geoŵetriĐal ǀariatioŶs PTV’s ǁere 
generated by adding a margin to the CTV. For prostate cancer patients a margin of 10 mm 
was added to the CTV. For head and neck cancer patients the PTV was directly delineated in 
the plaŶŶiŶg CT’s ǁithout preǀiouslǇ defiŶiŶg the CTV. Hoǁeǀer, geŶerallǇ a ŵargiŶ ďetǁeeŶ 
5 mm and 10 mm is implicitly assumed.   
 
2.2.3 Creation of the treatment plan  
After defining the target volume, the number of fractions and the desired treatment dose, 
the treatment plan is created by a physicist with the help of the Philips Pinnacle TPS. The 
physicist evaluates the treatment plan based on dose distribution and dose-volume 
histograms. Each final treatment plan is reviewed and verified by several radiation 
oncologists and physicians. After acceptance the plan is transferred to the treatment 
machines together with reference images and reference points determined during planning. 
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2.3 Patient positioning, Set-up and treatment 
For radiation treatment all patients were positioned on the treatment couch in the same 
way they were positioned for the treatment planning CT. Patients with head-and-neck 
cancer were immobilized with a customized thermoplastic mask that is secured to the couch. 
All prostate cancer patients were instructed on proper bowel and rectum preparation, and 
were treated with an empty rectum and a full bladder to help improve OAR sparing and 
minimize daily anatomic variations. Knee support and other immobilization equipment were 
applied. The patient was then positioned according to the reference marks on skin and mask 
by aligning them to the room lasers in the correct position. 
Verification images were obtained prior to irradiation at least once a week, depending on 
the frequency determined by the radiation oncologist in the treatment plan, and also 
depending on other factors, such as time constraints due to patient scheduling or other 
eventualities. The set-up verification images were compared to the reference images 
acquired from the planning CT scan. Two dimensional planar images were matched with 
digitallǇ reĐoŶstruĐted radiographies ;DRR’sͿ Đreated ďǇ the treatŵeŶt plaŶŶiŶg sǇsteŵ aŶd 
volumetric CBCT images were matched with the planning CT scan directly. Special software 
was used to match the verification image to the reference data set in all three dimensions. 
An initial automated grey scale match was performed to assess the coincidence of the 
anatomy with the reference image, which was followed by manual registration and 
ĐorreĐtioŶ. The patieŶt’s positioŶ ǁas theŶ adjusted aĐĐordiŶglǇ ďǇ eǆeĐutiŶg traŶslatioŶal 
shifts of the treatment couch (in anterior-posterior, superior-inferior or left-right direction) 
in order to ensure an optimal alignment of the target volume. Implementing a roll/pitch 
movement for adjustment of the couch is not possible.  
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2.4 Systematic and random set-up error 
As explained earlier, the terŵ ͞set-up error͟ or ͞set-up ǀariatioŶ͟ describes the discrepancy 
between the intended and actual treatment position. It includes a systematic and random 
component. It is usually calculated as a shift of the treatment field position when comparing 
a verification image against its corresponding reference.  
In order to calculate the systematic and random set-up errors for individual patients and for 
different groups of patients in this study, the alignment data obtained during treatment was 
evaluated according to the methodology introduced by van Herk (van Herk, 2004). The 
alignment data is collected from the individual couch shifts (in cm) realized in order to 
correctly align the target volume of the patient to the target volume defined in the reference 
images.  
 
2.4.1 Calculating the systematic and random set-up error for an individual patient 
For each individual patient in the study the mean of all the shifts recorded during treatment 
for each separate direction was calculated. This defines the systematic set-up error (µ) for 
eaĐh iŶdiǀidual patieŶt aŶd for eaĐh direĐtioŶ. The patieŶt’s sǇsteŵatiĐ set-up error (µ) 
resembles the average shift/deviation of the target volume from the position of the target 
volume during planning. 
The standard deviation (SD) of all the shifts for the individual patient and for each direction 
defines the patieŶt’s random set-up error (r). The patieŶt’s raŶdoŵ set-up error (r) shows 
the day-to-day variation of the target volume position from the mean position of the target 
volume.  
 
2.4.2 Calculating the systematic and random set-up error and the variation of the 
systematic set-up error for a specific population 
In order to obtain the systematic set-up error for a population (M) the mean of all the 
systematic set-up errors (µ) of all the individual patients included in this population is 
calculated for each direction. In other words, the average of all the mean shifts for all the 
individual patients in the population is calculated. The systematic set-up error for a 
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population (M) shows the average shift/deviation of all target volumes in the population 
from their position during planning. The systematic set-up error for a population (M) is an 
error that affects each patient in the population in the same magnitude or direction.  
The variation of the systematic setup error of the population (∑Ϳ, the population error 
spread, is defined as standard deviation (SD) of all the individual patient systematic errors 
(i.e. the standard deviation (SD) of all mean shifts (µ) per patient in the population). It 
indicates the patient-to-patient variation in the systematic deviation from the planning 
situation.  
The random set-up error of the population (σ), the random variation, is determined by 
calculating the root-mean-square (RMS) of the random setup errors observed for each 
patient in the population (i.e. the RMS of all individual patieŶt staŶdard deǀiatioŶs ;“D’sͿ). 
 
 
 
2.5 Retrospective evaluation of CTV-PTV margins 
The CTV-PTV margin is determined by applying the two margin recipes presented by Stroom 
et al. (1999) and by van Herk et al. (2000), which account for both population systematic and 
random errors.  The following equations were used:  
M=2∑+0.7σ (Stroom et al., 1999) 
and 
M=2.5∑+0.7σ (van Herk et al., 2000) 
 We calculated the CTV-PTV margins for both populations applying the values calculated by 
means of the alignment data. We further investigated if there was a difference between the 
calculated margins using the alignment data acquired with the help of the different imaging 
techniques. 
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2.6 Study population and alignment data 
The present study includes the data of 89 patients receiving image guided radiotherapy 
(IGRT) at the Department of Radiotherapy and Radiooncology at the Saarland University 
Medical Center from January 2013 to December 2013. Of these patients, 36 were treated for 
prostate cancer and 53 for head-and-neck cancer. Overall 3061 radiation fractions were 
analyzed retrospectively, 1324 for prostate cancer patients and 1737 for head-and-neck 
cancer patients. For 1260 of these fractions, 609 for prostate cancer patients and 651 for 
head-and-neck cancer patients, treatment targets were localized prior to radiation using 
different verification imaging techniques. The set-up verification images were matched with 
the reference set-up position as defined by the reference images obtained during treatment 
plaŶŶiŶg ;DRR’s or plaŶŶiŶg CT’sͿ, the patieŶt’s set-up accuracy was evaluated and necessary 
couch shifts for optimal alignment of the target volume were determined. The couch was 
then shifted accordingly in three dimensions, anterior-posterior (AP), superior-inferior (SI) 
and left-right (LR) to the corrected position.  The alignment data of these 1260 x 3 shifts was 
analyzed for this study in the MS Excel 2010 Software. Table 1 summarizes the number and 
distribution of fractions and verification images among the two patient populations included 
in this study.  
 
Table 1: Number and distribution of patients, fractions and verification images 
  
prostate cancer 
patients 
head-and-neck 
cancer patients 
Total 
Number of patients 36 53 89 
Number of radiation 
fractions 
1324 1737 3061 
Number of set-up 
verification  images 
609 651 1260 
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The 36 patients within the group of prostate cancer patients were treated during January 
2013 to October 2013. The average number of fractions for these patients was 37 and they 
on average received 17.7 set-up verification images during radiation treatment, i.e. images 
where acquired for approximately every other radiation fraction. The mean and standard 
deviation for the fractions and verification images for prostate cancer patients are shown in 
table 2. 
 
Table 2:  Prostate cancer patients - Statistic of fractions and images 
 Prostate cancer patients 
Mean 
Standard 
deviation Minimum Maximum 
Fractions 37 2.6 33 39 
Set-up verification images 17.7 3.9 10 34 
Percentage of images per fraction 45.30% 12% 
   
 
 
Within the collective of 53 patients with head-and-neck cancer, treated from January 2013 
to December 2013, the number of radiation fractions and set-up images varied widely. As 
shown in table 3, the number of fractions per patient ranged from 17 to 55, and the number 
of set-up images from 4 to 23. However, on average, 33 radiation fractions and 12.3 set-up 
images per patient were obtained, i.e. verification images where acquired for approximately 
every third radiation fraction. 
 
Table 3: Head-and-neck cancer patients - Statistic of fractions and images 
Head-and-neck cancer patients Mean 
Standard 
deviation 
Minimum Maximum 
Fractions 33 8.8 17 55 
Set-up verification images 12.3 4.5 4 23 
Percentage of images per fraction 37.4% 12% 
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3. Results 
 
3.1 Employment of the different linacs within both groups 
Since the three linacs in our clinic offer different imaging techniques it was important to 
evaluate which amount of the treatment fractions for each group was delivered with each of 
the different treatment machines. Obviously this distribution has an impact on the different 
imaging modalities used for each group since not all linacs provide all three imaging 
energies. Table 4 shows the amount of fractions and images delivered with each of the three 
different treatment machines for both head-and-neck and prostate cancer patients, as well 
as the subdivision of the acquired images into the different image modalities used at each 
treatment machine. Figures 5, 6 and 7 visualize these distributions.  
Table 4: Distribution of linacs and imaging modalities for both patient groups 
Head-and-neck cancer patients 
     6MV IBL kV 
fractions images 
images per 
fractions at 
each linac 
planar 
images CBCT 
planar 
images CBCT 
planar 
images CBCT 
ART1 551 220 40% 29 0 113 16 29 34 
ART2 981 357 36% 61 0 221 75 0 0 
ONC2 221 75 34% 59 16 0 0 0 0 
 
Prostate cancer patients 
     6MV IBL kV 
fractions images 
images per 
fractions at 
each linac 
planar 
images CBCT 
planar 
images CBCT 
planar 
images CBCT 
ART1 590 252 42% 23 0 50 15 87 77 
ART2 246 144 59% 12 0 59 73 0 0 
ONC2 489 210 43% 150 60 0 0 0 0 
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Figure 5 Distribution of the linacs used for treatment of the two patient populations 
 
 
As seen in Figure 5 the radiation treatment for head-and-neck cancer patients was 
predominantly delivered with the ART2 (56%), followed by the ART1 (31%) and with only a 
small number of fractions and images obtained with the ONC2 (13%). Radiation treatment 
for prostate cancer patients was generally delivered with the ART1 (44%) and the ONC2 
(37%), the ART2 (19%) was used the least for radiation treatment for prostate cancer 
patients. 
 
 
 
 
ONC2 
13% 
ART2 
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31% 
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ONC2 
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Figure 6: Distribution of planar images versus CBCT for each linac and each population 
Head-and-neck cancer patients 
 
 
Prostate cancer patients 
 
Figure 6 demonstrates that for set-up verification planar imaging is generally used a lot more 
frequently than three dimensional CBCT imaging for both populations. However, in 
comparison to head-and-neck cancer patients the frequency of CBCT imaging when treating 
prostate cancer images is a lot higher.  For prostate cancer patients treated with the ART 2 
as much as 50 % of the images acquired are CBCT images.  
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Figure 7: Percentage of each imaging modality used for the different linacs for each population 
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Figure 7 shows that when using the ART1 there were significant differences in the choice of 
image-modality used within both patient populations. When using the ART1 for treating 
prostate cancer patients, kilovoltage imaging was utilized in more than half of the 
treatments. This stands in contrast to the utilization when treating head-and-neck cancer 
patients. For head-and-neck cancer patients only approximately one third of the imaging 
technique used was kilovoltage imaging. The most commonly used imaging energy for head-
and-neck cancer patients when treated at the ART1 is IBL planar imaging. For both 
populations at the ART1 and the ART2 only a small amount of imaging used was 6MV, 
approximately 10-20%, and in these cases only planar images were obtained. For prostate 
cancer treatment at the ART1 half of the obtained kV imaging was three dimensional CBCT 
imaging, and at the ART2 half of the obtained IBL imaging was CBCT imaging.  
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Discussion and Conclusion (3.1) 
 
Selection of treatment machines: 
As already discussed and visualized in Figure 5 the distribution of the two patient 
populations to the individual linacs is very different. Head-and-neck cancer patients are 
treated at the ART2 in more than half (56%) of the fractions, followed by the ART1 (31%) and 
with only a small number of treatments delivered at the ONC2 (19%). In comparison 
prostate cancer patients are irradiated mainly at the ART1 (44%) and the ONC2 (37%) with 
only a small number of treatments delivered at the ART2 (19%). This constellation is due to 
different factors:  
As previously explained, the 6MV energies are matched at all three machines, but only the 
ART1 and ONC2 provide the 18MV energy. Therefore, 3DCRT prostate treatment, which is 
delivered with 18MV, can only be carried out at these two machines. Hence for prostate 
irradiation the ART2 is used only for the IMRT treatment fractions, which explains the small 
amount of fractions at the ART2. The ONC2 uses dynamic jaws for IMRT, which results in a 
slightly longer treatment time than the static jaw setting used by the ART1 and ART2. 
Therefore, IMRT are preferentially scheduled at the ART1 and ART2, in particular at the 
ART2. Taken together, as the ART2 only offers 6MV, and has static jaws, this machine is used 
for a large number of IMRT treatments, while the ONC2 is generally chosen for 3DCRT, 
especially for simple plans (arthrosis and prosthesis radiation). 
Since patients with prostate cancer are mostly treated with a combination of IMRT with 6MV 
and 3DCRT with 18MV and the linac ART2 is not capable of 18MV 3DCRT treatment, the 
percentage of treatment fractions at the ART2 is relatively small (19%). Since for head-and-
neck cancer treatment all fractions are delivered with IMRT generally the ART1 or the ART2 
are preferred over the ONC2. 
As the 6MV energy is available at all three treatment machines, and the 18MV energy is 
provided at both the ART1 and ONC2, there is still a lot of flexibility in choosing the machine 
for treatment. While it is technically possible to deliver IMRT at the ONC2, the linac ONC2 
does not present the first choice for IMRT treatment, due to the longer delivery time 
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(because of the dynamic jaws). Therefore, the final decision is based on factors such as free 
treatment slots, machine properties, and – importantly – imaging capability.  
Equipped with kilovoltage imaging, the ART1 of course offers the best imaging quality and is, 
therefore, more important for the treatment of prostate cancer patients, which require a 
higher soft tissue contrast than for e.g. head-and-neck cancer patients. Therefore, for 
prostate cancer patients the ART1 is the preferred treatment machine and for head-and-
neck cancer patients, where good imaging quality is still necessary, however, not as crucial 
as for prostate cancer patients, the ART2 is the favored treatment machine. This is reflected 
in our results which show that most treatment fractions for prostate cancer patients were 
delivered at the ART1 (44%). For head-and-neck cancer patients over half of the treatments 
were delivered at the ART2 (56%) and only few treatments took place at the ONC2 (13%). 
 
Planar imaging versus CBCT imaging:  
Our evaluation shows that planar imaging is clearly used more often than three dimensional 
CBCT imaging. The reason for this is simple: Although CBCT offers a much better imaging 
quality and is, therefore, more capable of detecting geometric inaccuracies, CBCT imaging 
also involves a much higher radiation dose adding to the toxicity of the radiation therapy. 
The compromise is to obtain planar imaging on a regular basis with CBCT imaging 
interspersed, which explains the difference in frequency of the two imaging techniques.  Our 
results have also shown that the frequency of CBCT images is a lot higher within the 
population of prostate cancer patients, which is plausible since prostate cancer treatment 
requires better imaging due to higher geometric variability and less rigid fixation methods. 
As discussed earlier at the ART2 only IMRT fractions can be delivered for prostate cancer 
treatment. IMRT is a much more complex radiation technique in comparison to 3DCRT and 
therefore requires a higher accuracy. This is reflected in our results which show that for 
prostate treatment at the ART2 as much as 50 % of the imaging used is CBCT. A reason for 
the circumstance that at the ONC2 treatment machine CBCT imaging is less often performed 
for prostate treatment (approx. 30%) might be the higher dosage involved with 6MV CBCT in 
comparison to IBL CBCT or kV CBCT. Also it is probable that for cases in which patients were 
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treated at the ONC2 as an exception, radiation therapists abstained from performing 6MV 
CBCT imaging, since it has a lower quality and higher dosage and instead performed 6MV 
planar imaging for this treatment fraction.  
 
Imaging modality used at the different treatment machines: 
Generally it is to be expected that for each linac the best imaging quality with the lowest 
dose is predominantly used and this is indeed the standard operating procedure (SOP) at our 
department. Figure 7 shows that this is the case for treatment at the ART2, which uses 
predominantly IBL imaging. At the ONC2 there is only 6MV imaging energy available which 
consequently is used for all imaging obtained at this machine.  However for IGRT at the ART1 
this cannot be confirmed. Although one would expect kV imaging to represent the highest 
percentage of imaging at the ART1, for head-and-neck cancer patients the dominant imaging 
technique used is IBL imaging with approximately 60%. For prostate cancer patients mostly 
kV imaging is used (approx. 60%), however, still a very large fraction of the images are IBL 
(approx. 30%). Since this result differs from our expectations it requires further discussion.  
Possible reasons for this result may be found in the general work flow. For patients that are 
treated at a linac for the first time, set-up fields need to be created in order to obtain kV 
images. Since this is time consuming it may not be worthwhile in some situations, for 
example, if the patient is usually treated at a different machine and using the ART1 for a 
treatment fraction presents an exception. As shown in Figure 5 and discussed above, head-
and-neck cancer patients were treated for the most part at the ART2, therefore when 
treated at the ART1 this often presented an exception for the patient. It is likely that in these 
situations IBL imaging may have been preferred due to already existing set-up fields for IBL 
imaging. 
Also the total time necessary for the acquisition of kV images is slightly larger than the time 
required for IBL imaging. Therefore, in the daily routine, in situations with limited time, IBL 
imaging might have been preferred. Another reason leading to the result in our study is the 
fact that at the beginning of the year 2013 the time necessary for the acquisition of kV 
planar image was much larger due to necessary gantry rotations of 180° in order to match 
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the images to the created set-up fields, hence adding to the difference in time and workload 
between IBL and kV imaging. This, however, has been modified and is now no longer 
necessary.  The discrepancy between our expectation and the actual employment of the 
different imaging modalities might also be simply due to lack of experience with kV imaging. 
KV imaging was still relatively new in our clinic and there might have been a habitual impact 
on the employment of imaging modalities.  However, the radiation therapists in our clinic 
have confirmed that today more kV imaging is realized at the ART1 and generally, wherever 
possible, the best imaging technique available is used.  
When looking at the fraction of IBL imaging for head-and-neck cancer patients at the ART1 it 
can be noted that almost all of the IBL images are planar images in comparison to the 
fraction of kV images, where CBCT and planar images are evenly distributed. A possible 
reason for this may be that since geometrical uncertainties are not as common for head-
and-neck cancer patients and planar imaging is often sufficient for set-up verification, IBL 
planar images might have been realized under the assumption that an IBL planar imaging 
might have a sufficiently low dose in comparison to kV CBCT imaging. However, although 
planar IBL images may imply a reduced dose in comparison with CBCT imaging, Ames (2015) 
and Dzierma et al. (2015) have shown that this is not necessarily the case, for head-and-neck 
cancer treatment the dose of kV CBCT imaging is still significantly lower than the dose of IBL 
planar images. 
Apart from the reasons mentioned above, the preference of using the better imaging 
techniques when treating prostate cancer is, of course, due to the fact that a higher soft-
tissue contrast is necessary in order to correctly align the target volume. In contrast, when 
aligning head-and-neck cancer patients, bony structures are often used as reference points. 
Also there is a much higher variability of inner organ movement in prostate cancer 
treatment. This is due to the anatomic site with differences in rectum and bladder 
movement and to the positioning of the patient on the treatment couch, which is not as 
reproducible as for head-and-neck cancer patients, where with the use of thermoplastic 
masks, better immobilization methods can be applied. Therefore in general the linac ART1 
and in particular kV imaging is used more frequently for prostate cancer patients. 
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3.2 Analysis of 3-dimensional conformal radiation therapy (3DCRT) versus 
intensity-modulated radiation therapy (IMRT) for prostate cancer patients 
While all patients within the head-and-neck cancer group were treated with IMRT, most of 
the prostate cancer patients received a 3 field 3DRCT with 18 MV for part of their radiation 
treatment, usually followed by a boost treatment with IMRT. We were interested in 
analyzing the employment of the different imaging modalities used for the two radiation 
techniques at our clinic. Table 5 and Figure 8 show the subdivision of 3DCRT and IMRT within 
the total number of radiation fractions for prostate cancer patients and the number of set-
up verification images acquired for each group. Also the distribution within the different 
types of imaging modalities is shown for 3DCRT and IMRT treatment fractions.  
 
Table 5: Distribution of IMRT and 3DCRT fractions for prostate cancer patients and number of 
different image modalities used within each group 
 
 
Figure 8: Number of images acquired during treatment with 3DCRT and IMRT and the distribution of 
these images within the different image modalities available 
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Table 6 shows the distribution and percentage of images obtained for each treatment 
fraction for 3DCRT and IMRT and the subdivision of these images into two dimensional 
planar and three dimensional CBCT imaging. The amount of images per fraction obtained is 
higher for IMRT than for 3DCRT.  58 % of the radiation fractions delivered with IMRT 
received verification imaging prior to treatment. In comparison, only 41 % of the radiation 
fractions delivered with 3DCRT received verification imaging.  While for 3DCRT treatment 
predominantly planar imaging is used as a means for set-up verification (72%), for IMRT this 
is not the case. For IMRT treatment fractions three dimensional CBCT imaging is used more 
frequently than planar imaging with 56% of the imaging being CBCT in comparison to 44 % 
planar imaging.  Figure 9 visualizes the distribution of CBCT versus planar images for both 
treatment techniques. 
Table 6: Distribution and percentage of images per fraction for 3DCRT and IMRT and the subdivision 
into planar images and CBCT images for each treatment technique 
 
  fractions images CBCT 
planar 
images 
Percentage  
of images 
per fraction 
Percentage 
of planar 
images per 
images  
Percentage 
of CBCT per 
images 
3DCRT 979 399 112 287 41% 72% 28% 
IMRT 347 202 113 89 58% 44% 56% 
  
 
Figure 9: Percentage of CBCT versus planar images within 3DCRT and IMRT 
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As shown in Figure 10 the distribution of CBCT versus planar images for 3DCRT and IMRT is 
different within the different imaging energies. For 6MV imaging is mostly planar and the 
percentage of CBCT images versus planar images is similar for both 3DCRT and IMRT, with 
approximately 80% being planar images. For IBL and kV imaging the distribution of CBCT and 
planar imaging is different for both treatment techniques. When acquiring IBL or kV images 
during 3DCRT mostly planar images are used (IBL = approx. 80% and kV = approx. 60%) in 
comparison to imaging during IMRT, where predominantly CBCT images are obtained (for 
both IBL and kV approx. 60% of the imaging obtained is CBCT).  
 
Figure 10: Percentage of CBCT images versus planar images for each imaging modality divided into 
3DCRT and IMRT treatment fractions 
 
 
Table 7 shows the percentage of each of the different imaging types available within the 
images acquired for the group of 3DCRT and IMRT treatment fractions.  The histogram in 
Figure 11 shows these percentages within the total number of treatment fractions delivered 
with 3DCRT and with IMRT.  
Table 7: Percentage of the different types of imaging modalities used for 3DCRT and IMRT factions 
  6MV IBL kV 
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3DCRT 39.6% 14.0% 17.5% 5.8% 14.8% 8.3% 
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Figure 11: Percentage of the different images obtained within the total number of fractions delivered 
with 3DCRT and IMRT 
 
 
 
The histogram in Figure 12 and the pie-chart in Figure 13 visualize the percentages listed in 
table 7. They show the distribution of the percentages of each different image modality 
used, for the number of images obtained during radiation treatment, within the group of 
radiation fractions treated with 3DCRT and within the group of radiation fractions treated 
with IMRT. 
 
Figure 12: Percentage of image modality used within the total amount of images acquired during 
3DCRT and IMRT fractions 
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Figure 13: Pie-chart showing the percentage of image modality used within the images acquired 
during 3DCRT and IMRT fractions  
 
 
 
 
 
each radiation energy.   
 
 
 
 
 
As can be seen in Figure 13, for 3DCRT predominantly 6MV planar imaging was used as 
method for set-up position verification. 39.6 % of all images acquired during 3DCRT are 6MV 
planar images. IBL planar images (17.5%) and KV planar images (14.8%) represent the next 
two largest groups within the total amount of images acquired during 3DCRT. With more 
than half of the images (54%), 6MV images (planar + CBCT) represent the largest group 
within images acquired during 3DCRT. This result differs from the group of images obtained 
during IMRT. For IMRT fractions the preferred imaging techniques used for position 
verification were IBL CBCT imaging (30.2%) and kV CBCT imaging (22.3%). Only a few images 
obtained during IMRT were 6MV images (16%), and in cases where 6MV images were 
obtained these were mostly planar images (11.9%). On the other hand, three dimensional 
CBCT imaging was favored for IBL and kV images obtained during IMRT, with 30% IBL CBCT in 
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Discussion and Conclusion (3.2) 
 
The amount of imaging acquired prior to each treatment is significantly higher for IMRT 
(58%) in comparison to 3DCRT (41%).  For 3DCRT mostly planar imaging is used as a means 
for set-up verification (72%), whereas for IMRT the amount of planar imaging versus CBCT 
imaging is different, as 56% of the obtained imaging is three-dimensional CBCT, in 
comparison to 44% planar imaging. The results show that at our clinic, for 3DCRT, the most 
commonly used imaging modality for position verification is planar imaging with 6MV. In 
contrast, for IMRT radiation the preferred imaging techniques used for set-up verification 
are three dimensional CBCT images with IBL and kV energies. These imaging techniques offer 
a much higher resolution and, therefore, allow a much more precise alignment of the target 
volume prior to radiation. It makes sense that the better imaging modalities are used for set-
up verification because IMRT is found to require a more precise positioning and alignment of 
the target volume since it is a more complex radiation technique in comparison to 3DCRT 
radiation.  Another factor influencing these results is the distribution to the different linacs. 
As mentioned earlier only the ONC2 and the ART1 are capable of delivering 3DCRT with 
18MV. This might explain the large amount of IBL imaging within the group of IMRT, since 
IMRT fractions were predominantly delivered at the ART2 and the best imaging modality 
available at the ART2 is IBL imaging. For prostate cancer 35% of the imaging realized during 
IMRT is delivered with kV energy. This suggests that when treated at the ART1, in most 
cases, the best imaging quality was used. These results confirm that in our clinic, when using 
more complex radiation techniques such as IMRT, better imaging techniques are applied for 
set-up verification imaging, allowing better alignment of the target volume.  
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3.3 Analysis of the different types of image modalities used for each group 
over the course of time 
 
In order to determine if there was a trend development within the different techniques of 
imaging modalities used for set-up verification in our clinic, the employment of the different 
image modalities was evaluated in relation to the course of time for the group of head-and-
neck cancer patients and for the group of  prostate cancer patients. First the results for the 
population of head-and-neck cancer patients will be presented. This will be followed by the 
results for the population of prostate cancer patients. 
 
 
3.3.1 Head-and-neck cancer patients 
 
Table 8 shows the monthly amount of radiation fractions delivered to head-neck cancer 
patients throughout the study and the total amount and percentage of set-up verification 
images per radiation fraction obtained each month. Most radiation fractions were delivered 
during the months of June to September. As can be seen in table 8 the months of October to 
December are shaded since only very few radiation fractions were analyzed during this time. 
Therefore, the radiation fractions during these three months are not representative for the 
group of head-and-neck cancer patients included in our study and as a result not taken into 
account in the further presentation of our findings. The percentage of images acquired per 
radiation fraction each month ranges between 32.1% and 53%. On average 37.9% of 
verification images per radiation fraction were obtained every month.  Apart from the 
months of October to December, which have been excluded, the month of June differs from 
the rest of the months with 53.4% of images acquired per fractions. An increase or decrease 
in the amount of images obtained per radiation fraction cannot be observed over the course 
of the year, there is no specific time trend regarding the amount of images per fraction. On 
average, for every third radiation fraction, a set-up verification image is obtained prior to 
radiation delivery. 
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Table 8:  Radiation fractions and set-up images per month, percentage of images per monthly 
radiation fractions for head-and-neck cancer patients 
 
month 
fractions 
per month 
images per 
month 
percentage 
of images 
per 
fractions 
January 211 82 38.9% 
Febuary 293 94 32.1% 
March 149 58 38.9% 
April 102 38 37.3% 
May 124 41 33.1% 
June 176 94 53.4% 
July 279 92 33.0% 
August 209 78 37.3% 
September 139 51 36.7% 
October 35 12 34.3% 
November 15 9 60.0% 
December 5 2 40.0% 
MEAN  187 70 37.9% 
 
 
Comparison of CBCT imaging and planar imaging for head-and-neck cancer patients 
The collected data was evaluated in terms of preferences for two dimensional planar 
imaging versus three dimensional conebeam CT (CBCT) imaging over time. Table 9 and Figure 
14 show that the percentage of CBCT images and planar images remains relatively consistent 
throughout the different months. An average of 78 % of the images acquired each month for 
set-up verification are two dimensional planar images, 22 % are cone beam CT images. No 
increasing or decreasing in the employment of either imaging technic is observed over time. 
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Table 9: Amount and percentage of planar images versus CBCT images acquired each month for 
head-and-neck cancer patients 
 
Month 
planar 
images 
CBCT 
 
Month 
planar 
images 
CBCT 
January 59 23 
 
January 72.0% 28.0% 
Febuary 78 16 
 
Febuary 83.0% 17.0% 
March 41 17 
 
March 70.7% 29.3% 
April 32 6 
 
April 84.2% 15.8% 
May 32 9 
 
May 78.0% 22.0% 
June 73 21 
 
June 77.7% 22.3% 
July 74 18 
 
July 80.4% 19.6% 
August 62 16 
 
August 79.5% 20.5% 
September 39 12 
 
September 76.5% 23.5% 
October 10 2 
 
October 83.3% 16.7% 
November 8 1 
 
November 88.9% 11.1% 
December 2 0 
 
December 100,0% 0.0% 
MEAN 54 15 
 
MEAN 78.0% 22.0% 
 
 
 
Figure 14: Percentage of planar images and CBCT per month for head-and-neck cancer patients 
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Comparison of monthly 6MV, IBL and kV imaging for head-and-neck cancer patients 
A summary, of the amount and percentages of 6MV, IBL and kV images obtained each 
month for head-and-neck cancer patients, is provided in Table 10. Figure 15 shows a 
visualization of the quantities of 6MV, IBL and KV images obtained each month. 
Table 10: Amount and percentage of 6MV, IBL and kV images acquired each month within the 
group of head-and-neck cancer patients 
  
fractions 
per 
month 
absolute number of images percentage of images per images total 
monthly images 
Month  6MV IBL kV 6MV IBL kV 
January 211 16 56 10 19.5% 68.3% 12.2% 
Febuary 293 18 70 6 19.1% 74.5% 6.4% 
March 149 19 33 6 32.8% 56.9% 10.3% 
April 102 9 27 2 23.7% 71.1% 5.3% 
May 124 18 20 3 43.9% 48.8% 7.3% 
June 176 27 52 15 28.7% 55.3% 16% 
July 279 27 57 8 29.3% 62% 8.7% 
August 209 14 57 7 17.9% 73.1% 9% 
September 139 10 38 3 19.6% 74.5% 5.9% 
October 35 4 5 3 33.3% 41.7% 25% 
November 15 2 7 0 22.2% 77.8% 0% 
December 5 0 2 0 0% 100% 0% 
MEAN 187 18 46 7 26.0% 62.0% 12.5% 
 
 
Figure 15: 6MV, IBL and kV images obtained each month for head-and-neck cancer patients 
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Figure 16 and Figure 17 compare and visualize the percentage of 6MV, IBL and kV imaging 
modalities applied during each month for head and neck cancer patients. IBL imaging is the 
most commonly used imaging technic every month, an average of 60-70 % of the monthly 
acquired images are IBL images. 6MV images represent the second largest amount of images 
with an average of 20-30 % of monthly images. The percentage of monthly obtained kV 
images ranges between 5.9 % and 16 %. In general, however, only a small number of the 
monthly obtained images are kV images, approximately an average of 10%. An exception is 
the month of June where 16 % of the imaging is kV. 
Figure 16: Percentage of 6MV, IBL and kV images per total of the monthly set-up images for head-
and-neck cancer patients 
 
 
Figure 17: Development of employment of the different imaging modalities over time for head-
and-neck cancer patients 
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Comparison of 6MV planar images and CBCT, IBL planar images and CBCT images and kV 
planar and CBCT images for head-and-neck cancer patients 
The imaging techniques used for radiation therapy were evaluated not only in terms of the 
energy used (6MV, IBL and kV), but also it was investigated whether two-dimensional planar 
images or three-dimensional CBCT images were acquired for set-up verification imaging. A 
summary, of the monthly number of times each of the six different image modalities was 
used, is provided in Table 11 and Figure 18. Table 12 shows the percentage of the images in 
relation to the total amount of images obtained each month.  
 
Table 11: Amount of images per imaging modality and per month for of head-and-neck cancer 
patients 
Month fractions 
per 
month 
6MV IBL kV 
  
planar 
images 
CBCT 
planar 
images 
CBCT 
planar 
images 
CBCT 
January 211 12 4 44 12 3 7 
Febuary 293 16 2 61 9 1 5 
March 149 18 1 19 14 4 2 
April 102 8 1 22 5 2 0 
May 124 16 2 15 5 1 2 
June 176 26 1 40 12 7 8 
July 279 26 1 43 14 5 3 
August 209 12 2 46 11 4 3 
September 139 9 1 30 8 0 3 
October 35 3 1 5 0 2 1 
November 15 2 0 6 1 0 0 
December 5 0 0 2 0 0 0 
MEAN 187 16 2 36 10 3 4 
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Figure 18: Number of 6MV-, IBL- and kV-planar images and number of 6MV-, IBL- and kV CBCT 
obtained each month for head-and-neck cancer patients 
 
 
 
 
Table 12: Percentage of different image modalities per total monthly images within the group of 
head-and-neck cancer patients 
Month 6MV IBL KV 
  
planar 
images 
CBCT 
Planar 
images 
CBCT 
planar 
images 
CBCT 
January 14.6% 4.9% 53.7% 14.6% 3.7% 8.5% 
Febuary 17.0% 2.1% 64.9% 9.6% 1.1% 5.3% 
March 31.0% 1.7% 32.8% 24.1% 6.9% 3.4% 
April 21.1% 2.6% 57.9% 13.2% 5.3% 0% 
May 39.0% 4.9% 36.6% 12.2% 2.4% 4.9% 
June 27.7% 1.1% 42.6% 12.8% 7.4% 8.5% 
July 28.3% 1.1% 46.7% 15.2% 5.4% 3.3% 
August 15.4% 2.6% 59.0% 14.1% 5.1% 3.8% 
September 17.6% 2.0% 58.8% 15.7% 0% 5.9% 
October 25.0% 8.3% 41.7% 0% 16.7% 8.3% 
November 22.2% 0% 66.7% 11.1% 0% 0% 
December 0% 0% 100% 0% 0% 0% 
MEAN 23.5% 2.6% 50.3% 14.6% 4.1% 4.8% 
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Figure 19 and Figure 20 compare and visualize the percentages of the six different imaging 
techniques used each month for the group of head-and-neck cancer patients in this study. 
IBL planar imaging is by far the most commonly used technique for set-up verification 
imaging within the group of head-and-neck cancer patients. With an average of 50.3 %, half 
of the images obtained each month were IBL planar images. With an average of 23.5 %, 6MV 
planar images represent the second most commonly used imaging technique, followed by 
IBL CBCT imaging with a monthly average of 14.6 %. The other three imaging techniques 
available, 6MV CBCT and KV planar images and KV CBCT were rarely used for set-up 
verification imaging, with a monthly average of 2.6 % for 6 MV CBCT, 4.8 % for KV CBCT and 
4.1 % for KV planar imaging. The percentage each of the different imaging modalities was 
used every month is relatively consistent over the course of time. A specific time trend for 
the employment of the different image modalities is not apparent.  
 
Figure 19: Percentage of images obtained in each different image modality per total monthly 
images for head-and-neck cancer patients 
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Figure 20: Development of employment of the different image modalities over time for head-and-
neck cancer patients 
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3.3.2 Prostate cancer patients 
Table 13 summarizes the monthly amount of radiation fractions delivered to prostate cancer 
patients throughout the study and the total amount and percentage of monthly set-up 
verification images per radiation fraction. Most radiation fractions were delivered during the 
months of May, June and July. The percentage of images acquired per radiation fraction 
each month varies from 41 % to 50 %, with an average of 46.7 % images per fraction. The 
month of March presents a clear exception. During March 58.8 % percent of treatment 
fractions received set-up verification imaging. However, it can be generally noted, that 
verification imaging is obtained for nearly every other fraction. There is no evident trend 
development over the course of time regarding the number of images per radiation fraction. 
For the months of January and February the number of fractions is so small since only 
patients that started treatment during these months were included in the study. Patients 
with already ongoing treatment, which was begun in the end of the year 2012, were not 
included. 
 
Table 13: Radiation fractions and set-up images per month, percentage of images per monthly 
radiation fractions for prostate cancer patients 
Month 
fractions per 
month 
images per 
month 
percentage of 
images per 
fractions 
January 23 10 43.5% 
February 53 22 41.5% 
March 68 40 58.8% 
April 193 98 50.8% 
May 223 105 47.1% 
June 232 108 46.6% 
July 242 99 40.9% 
August 165 68 41.2% 
September 91 42 46.2% 
October 34 17 50.0% 
MEAN 132.4 60.9 46.7% 
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Comparison of CBCT imaging and planar imaging for prostate cancer patients 
In addition, the data was evaluated in terms of the preference for two dimensional planar 
imaging versus three dimensional CBCT imaging over time. Table 14 and Figure 21 show that 
two-dimensional planar images are more commonly used than three-dimensional CBCT. The 
percentage of conebeam CT images and planar images is consistent throughout the different 
months. About 60-70 % of the images acquired each month for set-up verification were two 
dimensional planar images, 30-40 % were conebeam CT images. The mean monthly 
employment rates for the two different imaging techniques were 64 % for planar imaging 
versus 36 % for CBCT imaging. The largest deviation is seen in the months of February and 
August. In February only 22.7 % of the imaging is CBCT and in August as much as 48.5 % of 
the images are CBCT images. Apart from these months the distribution of the two imaging 
techniques remains similar. No increasing or decreasing employment of either imaging 
technique is observed over time. 
Table 14: Amount and percentage of planar images versus CBCT images acquired each month for 
prostate cancer patients 
Month 
planar 
images 
CBCT 
 
Month 
planar 
images 
CBCT 
January 6 4 
 
January 60.0% 40.0% 
February 17 5 
 
February 77.3% 22.7% 
March 24 16 
 
March 60.0% 40.0% 
April 58 40 
 
April 59.2% 40.8% 
May 63 42 
 
May 60.0% 40.0% 
June 72 36 
 
June 66.7% 33.3% 
July 65 34 
 
July 65.7% 34.3% 
August 35 33 
 
August 51.5% 48.5% 
September 29 13 
 
September 69.0% 31.0% 
October 12 5 
 
October 70.6% 29.4% 
MEAN 38.1 22.8 
 
MEAN 64.0% 36.0% 
 
Figure 21: Percentage of planar images and CBCT per month for prostate cancer patients  
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Comparison of monthly 6MV, IBL and kV imaging technique for prostate cancer patients 
A summary of the number and percentage of 6MV, IBL and kV images, obtained each month 
for prostate cancer patients, is provided in Table 15. Figure 22 shows a visualization of the 
number of 6MV, IBL and kV images obtained each month. 
 
Table 15: Number and percentage of 6MV, IBL and kV images acquired each month within the 
group of prostate cancer patients  
  
absolute number of images 
percentage of images per images 
total monthly images 
Month 6MV IBL kV 6MV IBL kV 
January 6 0 4 60.0% 0% 40.0% 
February 12 7 3 54.5% 31.8% 13.6% 
March 10 24 6 25.0% 60.0% 15.0% 
April 20 53 25 20.4% 54.1% 25.5% 
May 49 31 25 46.7% 29.5% 23.8% 
June 48 24 36 44.4% 22.2% 33.3% 
July 62 7 30 62.6% 7.1% 30.3% 
August 17 28 23 25.0% 41.2% 33.8% 
September 14 16 12 33.3% 38.1% 28.6% 
October 10 7 0 58.8% 41.2% 0% 
MEAN 24.8 19.7 16.4 43.1% 32.5% 24.4% 
 
Figure 22: Quantity of 6MV, IBL and kV images obtained each month for prostate cancer patients  
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Figure 23 and Figure 24 visualize the distribution of the percentage of 6MV, IBL and kV 
images within the total of set-up verification images obtained during each month. 6MV 
imaging represents the most commonly applied imaging technique within the group of 
prostate cancer patients in this study, with an average of 43.1 % of the total monthly 
obtained images. The mean percentage of monthly IBL images is 32.5 % and the mean 
percentage of monthly kV images is 24.4 %. However the percentage of the different image 
modalities used throughout the different months varies greatly. In the months of May, June 
and July 6MV imaging is clearly the most commonly used imaging technique, whereas during 
the months of March and April more IBL images were obtained. After falling from 40 % in 
January to about 14 % in February the percentage of kV imaging steadily increases again 
during the course of the year until October where it decreases once more. There is no visible 
development of a specific trend for the employment of an imaging modality over time. 
However, due to the small amount of fractions analyzed the month of October may not be 
representative. 
Figure 23: Percentage of 6MV, IBL and kV images per total of the monthly set-up images for 
prostate cancer patients 
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Figure 24: Development of employment of the different image modalities throughout time for  
prostate cancer patients 
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Comparison of 6MV planar images and CBCT, IBL planar images and CBCT images and kV 
planar and CBCT images for prostate cancer patients 
Table 16 and Figure 25 show the amount of each of the three different image modalities 
used for set-up verification imaging. Each of the energies is further divided into two-
dimensional planar imaging and three-dimensional CBCT imaging.  
 
Table 16: Absolute number of images per image modality and per month for prostate cancer 
patients 
Month 6MV IBL kV 
  
planar 
images CBCT 
planar 
images CBCT 
planar 
images CBCT 
January 5 1 0 0 1 3 
February 11 1 5 2 1 2 
March 7 3 12 12 5 1 
April 16 4 29 24 13 12 
May 33 16 14 17 16 9 
June 38 10 15 9 19 17 
July 44 18 6 1 15 15 
August 12 5 13 15 10 13 
September 12 2 10 6 7 5 
October 7 3 5 2 0 0 
TOTAL 185 63 109 88 87 77 
 
Figure 25: Number of 6MV-, IBL- and kV-planar images and number of 6MV-, IBL- and KV CBCT 
obtained each month for prostate cancer patients 
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Table 17 summarizes the percentage of the images obtained with the six different imaging 
techniques in relation to the total amount of monthly images. Figure 26 and Figure 27 
compare and visualize these percentages. 6MV planar imaging is the most commonly used 
technic for set-up verification imaging within the group of prostate cancer patients included 
in this study, with an average of 33.2 %, followed by IBL planar imaging with an average of 
18.8% of the total monthly images. The monthly average of the other four imaging 
techniques is similar and ranges from 9.9 % (6MV CBCT imaging) to 13.7 % (IBL CBCT 
imaging). A specific time trend for the employment of the different image modalities is not 
visible. As can be seen in the diagrams the amount of each different imaging technique used 
every month varies greatly.  
 
 
Table 17: Percentage of different image modalities per total monthly images within the group of 
prostate cancer patients 
Month 6MV IBL KV 
  
planar 
images CBCT 
planar 
images CBCT 
planar 
images CBCT 
January 50.0% 10.0% 0% 0% 10.0% 30.0% 
February 50.0% 4.5% 22.7% 9.1% 4.5% 9.1% 
March 17.5% 7.5% 30.0% 30.0% 12.5% 2.5% 
April 16.3% 4.1% 29.6% 24.5% 13.3% 12.2% 
May 31.4% 15.2% 13.3% 16.2% 15.2% 8.6% 
June 35.2% 9.3% 13.9% 8.3% 17.6% 15.7% 
July 44.4% 18.2% 6.1% 1.0% 15.2% 15.2% 
August 17.6% 7.4% 19.1% 22.1% 14.7% 19.1% 
September 28.6% 4.8% 23.8% 14.3% 16.7% 11.9% 
October 41.2% 17.6% 29.4% 11.8% 0% 0% 
MEAN 33.2% 9.9% 18.8% 13.7% 12.0% 12.4% 
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Figure 26: Percentage of images obtained in each different image modality per total monthly 
images for prostate cancer patients 
 
 
 
 
Figure 27: Development of employment of the different image modalities throughout time for 
prostate cancer patients 
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Discussion and Conclusion (3.3) 
 
These results have shown that the frequency of performing verification imaging prior to 
delivering the radiation treatment is very different for head-and-neck cancer patients versus 
prostate cancer patient. While prostate cancer patients receive set-up verification imaging 
for approximately every other treatment fraction, for head-and-neck cancer patients set-up 
verification imaging is only performed for approximately every third treatment fraction. 
When comparing the employment of two dimensional planar imaging versus three 
dimensional conebeam imaging for both populations, the results show that although the 
amount of each of the two imaging techniques remains largely consistent over the course of 
the months, there is a significant difference in the amount of the imaging techniques used 
between both patient populations. For prostate cancer patients a mean of 36.0 % of CBCT 
images acquired every month. The amount of three dimensional imaging is much higher 
than that of head-and-neck cancer patients with a monthly mean of 18.8%. As discussed 
earlier these results are due to the fact that prostate irradiation requires a much higher 
accuracy due to greater geometric variability.  
 Our analysis of the employment of the different imaging techniques used at our clinic did 
not show any clear development or trend over the course of the time evaluated in our study. 
After introduction of kV imaging, a new and better high resolution imaging technique, a clear 
change in the employment rates of the different imaging techniques was not visible over the 
course of the evaluated months. This might be due to the fact that by January 2013 the new 
imaging modality was already well established in the daily routine. Another possibility might 
be that the time period of 9 months was not long enough. An evaluation of a longer time 
period might bring different results.  
For head-and-neck cancer patients IBL planar images consistently make up more than half 
(55.5 %) of the monthly images, with 6MV planar imaging (21.6 %) coming in second place 
and IBL CBCT imaging in third (11.9 %). This differs from the distribution within the group of 
prostate cancer patients in our study. Here the most commonly used imaging technique 
throughout the months evaluated in this study is 6MV planar imaging with an average of 
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33.2 % and IBL planar imaging with an average of 18.8 %. Only one out of three lincas 
available in our clinic has the ability of obtaining images with kV energy, whereas two out of 
three linacs are equipped for IBL imaging and all three linacs are able obtain 6MV images. 
Taking this into consideration explains the generally small number of kV images. Within the 
group of head-and-neck cancer patients kV imaging makes up an average of 8 % of the show 
a much higher percentage of kV imaging per month. 24 % of the monthly set-up verification 
images for prostate cancer patients are kV images. The amount of planar and CBCT images is 
approximately even. Certainly the distribution of the imaging modalities used is impacted to 
some extent by the different employment of the three linacs within both patient 
populations. As shown earlier (Figure 5) prostate cancer patients were irradiated much more 
frequently at the ART 1 linac, which is the only one of the three machines in our clinic 
equipped for kV imaging. This obviously has an influence on the result that the amount of kV 
imaging within the prostate cancer group is almost three times as high as within the head-
and-neck cancer group. In conclusion these results are, to a considerable extent, due to the 
distribution of the two patient groups to the different linac machines, as well as due to the 
fact that for prostate cancer patients better imaging techniques are required in comparison 
to head-and-neck cancer patients. Also, as mentioned earlier, the radiation therapists have 
confirmed that today the amount of kV imaging at the ART1 has increased and generally the 
SOP to always use the best imaging technique for each treatment machine is followed. 
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3.4 Evaluation of the alignment data 
3.4.1 Overview of all recorded couch shifts  
Figure 28, Figure 29 and Figure 30 visualize the range of size of all individual couch shifts 
recorded during radiation treatment for both patient groups in the S-I, L-R and A-P 
directions. 
Figure 28 shows that for the group of head-and-neck cancer patients the range of couch 
shifts administered to compensate for the alignment of the target volume prior to the 
radiation ranges between -1 cm and 1 cm for all three directions. There are no major outliers 
within this group.  
As can be seen in Figure 29 the set-up error shifts for prostate cancer patients, with a few 
exceptions, all range within the same size, between -2 cm and 2 cm. These exceptions, 
however, are limited to three patients. Since the variations are so drastic compared to the 
average size of shifts among the rest of the prostate patients and therefore are not 
representative for the population of prostate cancer patients in this study, these three 
patients were excluded in the further evaluation of the data. Figure 30 shows the 
distribution of set-up errors measured for prostate cancer patients without inclusion of the 
three patieŶts, further referred to as ͞outlier͟. 
In Figure 30 it can be seen that, eǀeŶ after eliŵiŶatiŶg the three ͞outlier͟ patieŶts iŶ the 
prostate cancer patients group, there is still a wide range of size within the individual couch 
shifts administered for this group. The smallest variation within the couch shifts for prostate 
cancer patients can be seen in the anterior-posterior (A-P) direction. Here, with few 
exceptions the couch shifts range between -0.7 cm and 0.7 cm. For the superior-inferior (S-I) 
direction and for the left-right (L-R) direction the couch shifts are larger, with a range mainly 
between -1.5 cm to 1.5 cm, with a few exceptions, remaining between -2 cm to 2 cm. 
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Figure 28: Distribution of all individual set-up error shifts (in cm) in each direction for all head-and-
neck cancer patients 
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Figure 29: Distribution of all individual set-up error shifts (in cm) in each direction for all prostate 
cancer patients included in the study 
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Figure 30: Distribution of all individual set-up error shifts (in cm) in each direction for all prostate 
cancer patients included in the study without the three outliers 
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Discussion and conclusion (3.4.1) 
 
Comparing Figure 28 and Figure 30 it becomes obvious that there is a lot less variation in 
couch shift size within the population of heads-and-neck cancer patients in proportion to the 
population of prostate cancer patients. For head-and-neck cancer patients the couch shifts 
range between -1 cm and 1 cm for all three dimensions. For prostate cancer after exclusion 
of the three ͞outlier͟ patieŶts͟ the ĐouĐh shifts raŶge geŶerallǇ ďetǁeeŶ -1.5 cm and 1.5 cm. 
In the A-P dimension the couch shifts for prostate cancer patients are smallest ranging 
between -0.7 cm and 0.7 cm.  
These results are, as previously discussed, due to the fact that the target volume in head-
and-neck cancer patients is a lot more rigid in relation to the bony anatomy than the target 
volume in prostate cancer. Also the immobilization methods used in head-and-neck cancer 
treatment are more successful in reproducing the position of the target volume acquired 
during planning due to the better immobilization techniques (i.e. thermoplastic mask). In 
prostate cancer treatment there is also a much larger variability of the position of the target 
volume due to internal organ movement (i.e. rectum and bladder filling). 
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3.4.2 Systematic and random set-up error 
For each patient included in this study and for each patient population the systematic and 
random setup error was calculated according to the methodology by van Herk (2004) 
explained in methods and materials.  
Systematic (µ) and random (r) set-up errors for each individual patient 
Table 18 and Table 19 show the mean set-up error for each individual patient and for each of 
the three dimensions (S-I, L-R and A-P) in the two patient populations, defined as the 
systematic set-up error (µ) of the patient. Additionally, the standard deviation (SD) of the 
mean shift for each individual patient is listed, defined as the random error (r) for each 
individual patient.  
The mean set-up error, the systematic set-up error for each individual patient (µ), reveals 
the exact direction in which the couch was shifted after image verification at an average. 
This means the average size (in cm) and direction in which the target volume during the 
individual treatment fractions deviated from the position of the target volume during 
treatment planning. It is consistent for all individual fractions and therefore is called the 
systematic set-up error (sometimes also referred to as the preparation set-up error).  
The random set-up error ;rͿ is ĐoŶsidered the dailǇ ǀariatioŶ of the patieŶt’s set-up from the 
mean target volume position. Random set-up errors vary from fraction to fraction. As 
mentioned earlier, in order to determine the random set-up error (r) for each patient in the 
two populations, the standard deviation (SD) of the patients mean set-up error (i.e. the 
systematic setup error (µ)) is calculated. 
Figure 31 and Figure 33 shoǁ the raŶge of the iŶdiǀidual patieŶt’s sǇsteŵatiĐ errors ;µͿ for 
each direction for head-and-neck cancer and prostate cancer patient populations 
respectively.  Figure 32 and Figure 34 show the range of the systematic errors (µ) of the 
individual patients compared with Gaussian distribution curves, for each patient population 
and for each direction. 
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Table 18: Systematic (µ) and random (r) set-up errors for all individual head-and-neck cancer 
patients in each direction 
 
mean shift in each direction (cm) 
 
SD of mean shifts in each direction (cm) 
patient S-I L-R A-P  patient S-I L-R A-P 
1 0.07 0.00 -0.03  1 0.17 0.14 0.14 
2 0.09 -0.07 -0.01  2 0.29 0.22 0.21 
3 -0.09 -0.05 -0.12  3 0.13 0.19 0.17 
4 0.17 0.02 0.07  4 0.38 0.14 0.27 
5 0.06 0.26 -0.07  5 0.23 0.35 0.15 
6 0.03 0.15 -0.05  6 0.09 0.16 0.11 
7 -0.02 0.01 -0.12  7 0.09 0.11 0.11 
8 -0.04 0.07 0.04  8 0.32 0.14 0.26 
9 0.10 0.22 0.04  9 0.13 0.27 0.12 
10 -0.02 0.05 -0.05  10 0.40 0.14 0.21 
11 0.16 0.23 0.20  11 0.18 0.19 0.12 
12 0.03 -0.02 0.09  12 0.17 0.15 0.14 
13 -0.02 0.13 -0.03  13 0.12 0.15 0.12 
14 0.23 -0.03 -0.03  14 0.19 0.16 0.14 
15 0.05 0.11 -0.13  15 0.30 0.23 0.31 
16 0.17 0.27 -0.12  16 0.14 0.18 0.11 
17 0.06 0.01 0.11  17 0.27 0.25 0.26 
18 0.14 0.23 0,04  18 0.13 0.14 0.13 
19 -0.12 0.12 -0.09  19 0.21 0.12 0.30 
20 0.11 0.01 0.02  20 0.14 0.23 0.22 
21 -0.08 0.10 0.14  21 0.19 0.22 0.16 
22 -0.01 -0.01 -0.12  22 0.22 0.30 0.40 
23 -0.03 0.08 0.00  23 0.14 0.26 0.10 
24 0.02 0.24 0,21  24 0.23 0.22 0.27 
25 0.01 0.11 -0.08  25 0.38 0.48 0.18 
26 -0.02 0.18 -0.10  26 0.15 0.19 0.17 
27 0.02 0.14 -0.06  27 0.15 0.17 0.14 
28 0.09 0.04 -0.08  28 0.11 0.17 0.14 
29 0.09 0.24 -0.06  29 0.14 0.13 0.13 
30 0.20 0.00 -0.16  30 0.18 0.15 0.09 
31 0.04 0.00 -0.03  31 0.14 0.08 0.18 
32 -0.02 0.10 -0.23  32 0.15 0.17 0.17 
33 0.21 0.16 0.01  33 0.29 0.20 0.11 
34 0.07 0.16 -0.07  34 0.17 0.15 0.23 
35 -0.19 0.08 -0.05  35 0.33 0.23 0.16 
36 0.03 -0.13 -0.03  36 0.11 0.18 0.16 
37 0.03 0.03 -0.05  37 0.11 0.14 0.13 
38 0.07 -0.07 -0.10  38 0.38 0.24 0.15 
39 0.00 -0.05 0.08  39 0.16 0.14 0.11 
40 0.02 0.00 -0.06  40 0.25 0.21 0.20 
41 0.00 0.05 -0.02  41 0.15 0.07 0.04 
42 0.09 0.05 -0.11  42 0.43 0.10 0.13 
43 -0.07 -0.03 -0.03  43 0.25 0.09 0.16 
44 0.08 -0.08 -0.06  44 0.12 0.16 0.10 
45 0.01 0.04 -0.06  45 0.26 0.15 0.19 
46 0.01 0.22 -0.01  46 0.18 0.21 0.19 
47 0.33 0.13 -0.30  47 0.27 0.12 0.36 
48 0.00 -0.03 0.00  48 0.06 0.07 0.08 
49 -0.02 -0.03 0.07  49 0.16 0.16 0.17 
50 -0.13 0.05 0.24  50 0.18 0.17 0.27 
51 -0.04 0.09 -0.02  51 0.17 0.22 0.09 
52 -0.22 -0.03 -0.15  52 0.23 0.04 0.21 
53 -0.03 0.02 -0.02  53 0.12 0.12 0.26 
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Figure 31: Range of all systematic set-up errors (µ) for each individual head-and-neck cancer 
patient in each direction in cm. 
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Figure 32: Distribution of shifts for head-and-neck cancer patients and Gaussian fit 
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Table 19: Systematic (µ) and random(r) set-up errors for all individual prostate cancer patients in 
each direction 
mean of shifts in each direction (cm) 
 
SD of mean shifts in each direction (cm) 
patient  S-I L-R A-P  patient S-I L-R A-P 
1 0.08 0.02 -0.02  1 0.35 0.32 0.24 
2 -0.08 -0.30 -0.09  2 0.28 0.30 0.20 
3 -0.05 0.16 0.01  3 0.36 0.37 0.22 
4 0.21 -0.16 -0,06  4 0.15 0.30 0.18 
5 0.09 0.08 -0.06  5 0.34 0.21 0.16 
6 -0.08 0.00 0.13  6 0.40 0.41 0.16 
7 -0.05 0.08 0.24  7 0.33 0.40 0.26 
8 -0.07 -0.13 -0.16  8 0.29 0.39 0.18 
9 0.07 0.11 0.00  9 0.27 0.35 0.13 
10 -0.03 0.06 -0.02  10 0.29 0.23 0.15 
11 -0.29 -0.04 -0.21  11 0.28 0.46 0.25 
12 -0.38 -0.18 -0.29  12 0.46 0.60 0.32 
13 0.02 -0.18 -0.28  13 0.30 0.24 0.21 
14 0.23 -0.06 -0.19  14 0.18 0.43 0.20 
15 -0.14 0.31 -0.12  15 0.31 0.38 0.15 
16 0.11 -0.10 0.16  16 0.28 0.29 0.20 
17 -0.04 0.29 -0.15  17 0.36 0.38 0,.17 
18 -0.22 -0.06 0.10  18 0.43 0.30 0.42 
19 0.23 0.07 -0.03  19 0.22 0.27 0.11 
20 -0.18 -0.13 0.02  20 0.37 0.49 0.16 
21 0.02 0.21 0.22  21 0.50 0.71 0.32 
22 -0.33 -0.10 -0.22  22 0.37 0.24 0.41 
23 -0.22 -0.17 -0.29  23 0.52 0.53 0.16 
24 -0.23 -0.03 -0.13  24 0.46 0.48 0.17 
25 0.25 -0.02 0.07  25 0.48 0.52 0.30 
26 -0.35 -0.33 -0.05  26 0.32 0.41 0.23 
27 -0.06 -0.63 -0.02  27 0.19 0.39 0.23 
28 0.08 0.08 0.28  28 0.36 0.47 0.30 
29 0.05 -0.12 -0.09  29 0.19 0.28 0.17 
30 0.00 0.04 0.09  30 0.41 0.41 0.22 
31 -0.07 -0.01 -0.05  31 0.72 0.53 0.51 
32 -0.13 -0.19 0.04  32 0.48 0.37 0.16 
33 0.13 -0.12 -0.29  33 0.28 0.83 032 
Outlier 
patients    
 Outlier 
patients 
   
34 0.08 -0.31 -0.09  34 0.38 0.99 0.21 
35 0.03 0.14 0.42  35 0.38 0.88 1.42 
36 0.08 -0.26 0.04  36 0.30 0.88 0.59 
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Figure 33: Range of all systematic set-up errors (µ) for each individual prostate cancer patient in 
each direction in cm. 
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Figure 34: Distribution of shifts for prostate cancer patients and Gaussian fit 
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Discussion and conclusion (3.4.2) 
 
Figure 31 shows that the systematic set-up errors (µ) for the individual head-and-neck 
cancer patients range mainly (with few exceptions each), within -0.15 cm and 0.2 cm for the 
S-I direction, within -0.1 cm and 0.3 cm for the L-R direction and within -0.1 cm and 0.1 cm 
for the A-P direction. For head-and-neck cancer patients the systematic set-up error (µ), 
therefore, is smallest in the A-P direction. As mentioned earlier, for prostate cancer patients, 
the range of the systematic set-up errors (µ) in each direction is larger in comparison to 
head-and-neck cancer patients. Figure 33 shows that the range is within -0.4 cm and 0.25 cm 
in the S-I direction, within -0.3 cm and 0.1 cm in the L-R direction and -0.3 cm and 0.2 cm in 
the A-P direction. 
The random error (r) for head-and-neck cancer patients ranges from 0.06 cm to 0.43 cm in 
the S-I direction, from 0.07 cm to 0.48 cm in the L-R direction and from 0.09 cm to 0.40 cm in 
the A-P direction. The random error (r) for prostate cancer patients (without the outlier 
patients) ranges from 0.15 cm to 0.72 cm for the S-I direction, from 0.21 cm to 0.83 cm for 
the L-R direction and from 0.11 cm to 0.51 cm for the A-P direction. Consistently with the 
results for the systematic set-up errors (µ) for both patient populations, these results reveal 
that the random set-up error (r) is considerably larger for prostate cancer patients in 
comparison to head-and-neck cancer patients.  
The random error (r) differs distinctly for each patient and each direction, with values 
smaller than 0.5 cm for head-and-neck cancer patients and smaller than 0.9 cm for prostate 
cancer patients. Some individual patients have a larger random error, for example head-and-
neck cancer patient 25 with random errors of 0.38 cm, 0.48 cm and 0.18 cm for the S-I, L-R 
and A-P directions. For other patients the calculated random error is close to zero, i.e. head-
and-neck cancer patient 48 with values of 0.06 cm, 0.07 cm and 0.08 cm for the S-I, L-R and 
A-P directions. This is due to the fact that the different factors affecting the position of the 
target volume in each patient have a different impact on each individual patient.  These 
factors include weight loss, internal organ motion, tumor shrinkage or other anatomic 
changes, the fit of the fixation mask, and the agitation of a patient during treatment.  
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The Gaussian distribution curves in Figure 32 and Figure 34 show that the sizes of the 
individual couch shifts realized after set-up verification imaging in order to compensate for 
geometrical variations are distributed around zero for both populations. However, when 
comparing the Gaussian curves clear differences can be seen between the two populations. 
Again it can be seen that the sizes of the mean individual shifts for prostate cancer patients 
are more widely spread in comparison to the head-and-neck cancer shifts.  
 
 
3.4.3 The mean absolute shift for each individual patient 
In addition to the individual systematic set-up error (µ) (the mean shift) the mean absolute 
shift for each individual patient was calculated. The ͞absolute shift͟ refers to the actual size 
(in cm) the couch was shifted in order to align the target volume correctly to the reference 
image, without taking into consideration the sign of the shift value. Calculating the mean 
absolute shift for each patient discloses how much in actual size (in cm) the position of the 
target volume differed from the reference target volume position defined during treatment 
planning as an average. 
Table 20 and Table 21 show the mean absolute shift for all individual patients in each 
population and in each direction, as well as the standard deviation of the mean absolute 
shift in each direction for each individual patient, thus the average absolute size of the daily 
variation is shown for each patient. Figure 35 and Figure 36 show the range of the individual 
patieŶt’s ŵeaŶ aďsolute shifts for eaĐh direĐtioŶ. 
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Table 20: Mean absolute shift and standard deviation of the mean absolute shift for all individual 
head-and-neck cancer patients in each direction 
 
mean shift in each direction (cm) 
 
SD of mean shifts in each direction (cm) 
patient S-I L-R A-P  patient S-I L-R A-P 
1 0.13 0.11 0.06  1 0.13 0.09 0.12 
2 0.21 0.19 0.16  2 0.21 0.14 0.14 
3 0.12 0.14 0.17  3 0.11 0.15 0.12 
4 0.32 0.10 0.23  4 0.27 0.10 0.16 
5 0.18 0.36 0.13  5 0.16 0.24 0.10 
6 0.05 0.16 0.06  6 0.08 0.14 0.10 
7 0.07 0.08 0.12  7 0.07 0.08 0.11 
8 0.27 0.13 0.19  8 0.18 0.09 0.19 
9 0.12 0.29 0.11  9 0.11 0.19 0.06 
10 0.31 0.12 0.17  10 0.26 0.09 0.12 
11 0.22 0.26 0.20  11 0.11 0.14 0.12 
12 0.12 0.09 0.13  12 0.12 0.13 0.09 
13 0.09 0.13 0.08  13 0.09 0.15 0.09 
14 0.23 0.12 0.12  14 0.19 0.12 0.08 
15 0.27 0.17 0.27  15 0.14 0.19 0.21 
16 0.17 0.29 0.12  16 0.14 0.14 0.11 
17 0.19 0.21 0.22  17 0.20 0.14 0.18 
18 0.16 0.24 0.11  18 0.11 0.13 0.09 
19 0.20 0.14 0.23  19 0.14 0.09 0.21 
20 0.14 0.20 0.18  20 0.11 0.12 0.13 
21 0.14 0.20 0.18  21 0.15 0.14 0.12 
22 0.17 0.28 0.31  22 0.13 0.11 0.28 
23 0.08 0.24 0.10  23 0.11 0.12 0.00 
24 0.16 0.30 0.31  24 0.17 0.17 0.18 
25 0.31 0.36 0.15  25 0.22 0.33 0.13 
26 0.13 0.20 0.17  26 0.07 0.17 0.10 
27 0.08 0.14 0.11  27 0.12 0.17 0.11 
28 0.11 0.13 0.12  28 0.10 0.11 0.11 
29 0.12 0.24 0.12  29 0.12 0.13 0.09 
30 0.23 0.11 0.16  30 0.14 0.10 0.09 
31 0.13 0.06 0.14  31 0.07 0.05 0.12 
32 0.11 0.15 0.23  32 0.11 0.12 0.17 
33 0.28 0.18 0.06  33 0.22 0.19 0.10 
34 0.13 0.16 0.16  34 0.12 0.15 0.18 
35 0.28 0.18 0.13  35 0.25 0.15 0.11 
36 0.08 0.18 0.13  36 0.08 0.13 0.11 
37 0.06 0.10 0.07  37 0.10 0.10 0.12 
38 0.33 0.18 0.12  38 0.19 0.17 0.13 
39 0.13 0.12 0.08  39 0.09 0.09 0.11 
40 0.22 0.18 0.15  40 0.13 0.12 0.15 
41 0.10 0.05 0.02  41 0.11 0.07 0.04 
42 0.39 0.08 0.14  42 0.21 0.08 0.10 
43 0.16 0.07 0.13  43 0.20 0.07 0.11 
44 0.09 0.16 0.08  44 0.11 0.08 0.09 
45 0.21 0.09 0.15  45 0.16 0.12 0.12 
46 0.14 0.23 0.14  46 0.12 0.20 0.12 
47 0.37 0.13 0.33  47 0.22 0.12 0.32 
48 0.03 0.03 0.07  48 0.05 0.07 0.05 
49 0.11 0.13 0.14  49 0.11 0.10 0.12 
50 0.19 0.13 0.32  50 0.11 0.10 0.14 
51 0.12 0.16 0.06  51 012 0.17 0.07 
52 0.22 0.03 0.20  52 0.23 0.04 0.16 
53 0.07 0.12 0.20  53 0.10 0.10 0.19 
. 
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Figure 35: Range of all mean absolute shifts for each individual head-and-neck cancer patient in 
each direction in cm. 
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Table 21: Mean absolute shift and standard deviation of the mean absolute shift for all individual 
prostate cancer patients in each direction 
 
mean of absolute shifts in each direction (cm) 
 
SD of absolute shifts in each direction (cm) 
patient S-I L-R A-P 
 
patient S-I L-R A-P 
1 0.26 0.23 0.18 
 
1 0.25 0.22 0.16 
2 0.20 0.34 0.16 
 
2 0.22 0.26 0.15 
3 0.27 0.35 0.19 
 
3 0.25 0.20 0.12 
4 0.21 0.24 0.16 
 
4 0.15 0.24 0.11 
5 0.24 0.13 0.10 
 
5 0.26 0.18 0.14 
6 0.30 0.30 0.18 
 
6 0.28 0.28 0.10 
7 0.27 0.31 0.31 
 
7 0.20 0.26 0.18 
8 0.24 0.32 0.17 
 
8 0.18 0.26 0.17 
9 0.21 0.27 0.08 
 
9 0.19 0.25 0.10 
10 0.23 0.17 0.12 
 
10 0.18 0.16 0.09 
11 0.36 0.34 0.28 
 
11 0.18 0.31 0.17 
12 0.48 0.52 0.37 
 
12 0.36 0.35 0.22 
13 0.26 0.27 0.31 
 
13 0.15 0.14 0.17 
14 0.23 0.29 0.24 
 
14 0.18 0.33 0.15 
15 0.24 0.39 0.13 
 
15 0.25 0.28 0.14 
16 0.21 0.25 0.21 
 
16 0.22 0.17 0.16 
17 0.31 0.34 0.19 
 
17 0.19 0.34 0.11 
18 0.36 0.23 0.23 
 
18 0.33 0.20 0.36 
19 0.24 0.19 0.08 
 
19 0.21 0.21 0.08 
20 0.33 0.41 0.13 
 
20 0.25 0.30 0.10 
21 0.41 0.64 0.36 
 
21 0.29 0.37 0.15 
22 0.39 0.21 0.38 
 
22 0.30 0.15 0.25 
23 0.48 0.49 0.30 
 
23 0.31 0.26 0.14 
24 0.43 0.40 0.20 
 
24 0.29 0.26 0.08 
25 0.46 0.42 0.26 
 
25 0.29 0.31 0.16 
26 0.42 0.36 0.21 
 
26 0.21 0.38 0.12 
27 0.15 0.63 0.19 
 
27 0.14 0.39 0.13 
28 0.32 0.41 0.36 
 
28 0.20 0.24 0.20 
29 0.14 0.21 0.13 
 
29 0.14 0.21 0.14 
30 0.34 0.29 0.17 
 
30 0.23 0.30 0.17 
31 0.57 0.38 0.36 
 
31 0.45 0.37 0.36 
32 0.34 0.29 0.11 
 
32 0.36 0.29 0.13 
33 0.22 0.66 0.34 
 
33 0.22 0.52 0.27 
Outlier 
patients     
Outlier 
patients    
34 0.33 0.66 0.17 
 
34 0.21 0.80 0.16 
35 0.31 0.39 0.54 
 
35 0.22 0.80 1.38 
36 0.23 0.54 0.35 
 
36 0.21 0.75 0.48 
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Figure 36: Range of all absolute shifts for each individual prostate cancer patients in each direction in cm. 
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Figure 35 shows that the sizes of the average absolute shifts for the individual head-and-
neck cancer patients are similar within the three directions, the A-P direction having the 
smallest variation ranging mainly from 0.05 cm to 0.25 cm, in comparison to the S-I direction 
with values between 0.05 cm and approximately 0.35 cm and to the L-R direction with values 
ranging mainly from 0.05 cm to 0.30 cm. For prostate cancer patients the mean absolute 
shifts are larger in all three dimensions. In Figure 36 the average absolute shifts for each 
individual patient are shown to be largest in the L-R direction, ranging mainly within 0.1 cm 
and 0.65 cm, in comparison to 0.2 cm and 0.45 cm in the S-I direction and 0.1 cm to 0.4 cm 
in the A-P direction.  
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3.4.4 Differences in set-up errors shown in the example of individual patients 
 
In order to demonstrate the large differences between individual patients within a patient 
population a boxplot (Figure 37) was created. The boxplot shows examples of a patient with 
a very large set-up variability (poor) and a patient with a very small set-up variation (good), 
as well as a representative average set-up error (total) for both head-and-neck cancer 
patients and prostate cancer patients.  
 
Figure 37: Boxplot showing the range of set-up errors within both patient populations - showing 
sample patients with good, poor and average (total) set-up accuracy 
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Discussion and conclusion: (3.4.3 and 3.4.4) 
 
Overall, these results show that the dimension of the systematic set-up errors (µ) for both 
head-and-neck cancer patients and prostate cancer patients is minor, with values close to 
zero in all of the three directions. In addition, there is no specific trend visible that would 
indicate a dominant deviation in a certain direction, thus a systematic set-up error which 
results in a systematic deviation of the target volume to a certain direction is not evident. 
These are important results confirming the quality assurance of the delivery of radiation 
therapy at our clinic. Furthermore, these results have confirmed that the random error is a 
lot larger for prostate cancer patients in comparison to head-and-neck cancer patients due 
to larger geometric variability of target volumes for prostate cancer patients in comparison 
to head-and-neck cancer patients. However, our results also show that for individual 
patients within a population the random set-up error might be very different. Some 
individual patients have a large random set-up error with large couch shifts necessary in 
order to compensate for these set-up errors. For other patients there is only a minimal 
variation of the position of the target volume evident after set-up verification imaging. The 
fact that random errors might be very different for individual patients needs to be taken into 
consideration when treating patients. 
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3.5 Population systematic errors (M), variation of population systematic 
errors ;∑Ϳ aŶd populatioŶ raŶdoŵ errors ;σ) 
 
3.5.1 Errors of both populations for combined imaging techniques 
As previously explained in Methods and Materials, according to van Herks (2004) 
methodology, the systematic set-up error within a population of patients (M) is determined 
by calculating the meaŶ of all the iŶdiǀidual patieŶt’s sǇsteŵatiĐ set-up errors (µ). The 
population systematic error (M) indicates any potential systematic error that affects all 
patients and all fractions within a specific population.  The variation (∑Ϳ of the population 
systematic set-up error (M) is obtained by calculating the standard deviation (SD) of all the 
individual patient systematic errors. The variation (∑Ϳ of the population systematic set-up 
error indicates the patient-to-patient variation in the systematic deviation from the planning 
situation. The random set-up error (σ) for a population of patients is defined by calculating 
the root-mean-square (RMS) of the random set-up errors recorded for each patient in the 
population. Table 22 shows the results of the calculations for the population systematic 
setup error (M), variation of population systematic error (∑Ϳ and population random set-up 
error (σ)  for head-and-neck cancer and prostate cancer patients in all three directions. 
 
Table 22: population systematic setup error (M), variation of population systematic error (∑Ϳ and 
population random error (σ) for head-and-neck cancer and prostate cancer patients in the S-I, L-R 
and A-P directions 
 
As anticipated the population systematic set-up error (M) for both populations is 
approximately zero in all three directions.  The values for the population of head-and-neck 
cancer patients are 0.03 cm for the S-I direction, 0.07 cm for the L-R direction and -0.03 cm 
  
 population 
systematic setup error 
(M) (cm)   
variaton of 
population systematic 
error ;∑Ϳ ;cŵͿ   
population random 
error ;σͿ ;cŵͿ 
  S-I L-R A-P 
 
S-I L-R A-P 
 
S-I L-R A-P 
Head-and-neck cancer 
patients 
0.03 0.07 -0.03   0.10 0.10 0.10   0.22 0.19 0.19 
Prostate cancer patients -0.03 -0.05 -0.03   0.16 0.18 0.17   0.37 0.49 0.35 
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for the A-P direction. The values for the population of prostate cancer patients are -0.03 cm 
for the S-I direction, -0.05 cm for the L-R direction and -0.03 cm for the A-P direction.  All 
values are smaller than 1 mm.  
For the results of the variation of the population systematic error (∑Ϳ differeŶĐes ĐaŶ ďe seeŶ 
within both patient population errors. The variation of the population systematic error (∑Ϳ is 
larger for prostate cancer patients with values of 0.16 cm (S-I), 0.18 cm (L-R), and 0.17 cm (A-
P) in comparison to 0.10 cm in all three directions for head-and-neck cancer patients. The 
biggest difference between the two patient groups can be found in the calculation of the 
population random error (σ). For head-and-neck cancer patients, the population random 
error (σ) is 0.19 cm for the L-R and A-P direction and slightly larger with 0.22 cm for the S-I 
direction. In contrast, the population random error (σ) for prostate cancer patients is 
considerably larger with values of 0.37 cm (S-I), 0.49 cm (L-R) and 0.35 cm (A-P).  
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Discussion and conclusion (3.5.1)  
 
The results for the population systematic error M is nearly zero for both patients 
populations. This confirms that there is no relevant systematic set-up error (M) in our clinic 
which systematically affects the entire patient population. This means there is practically no 
error in the individual patient set-up that affects all the patients of a specific population in 
the same way. This confirms the efficiency of the quality assurance measures realized at our 
clinic. These results also reveal that the variation of the population systematic error (∑Ϳ is 
slightly larger for prostate cancer patients. The biggest difference our results show is, as 
mentioned earlier, the large difference between the population random errors (σ) for both 
patient groups. The target volume in prostate cancer patients is subject to a much wider set-
up variation in comparison to head-and-neck cancer patients. This has been shown earlier in 
the results shown in figures 31, 32, 33 and 34 presenting the mean set-up error for individual 
patients of both populations. The largest random population error (σ) for prostate cancer 
patients can be found in the L-R dimension (0.49 cm). In comparison, for head-and-neck 
cancer patients the random population error (σ) is found to be slightly larger in the S-I 
dimension. However, the random population error (σ) for head-and-neck cancer patients is 
very similar for all three dimensions. A possible reason for this might be that the 
thermoplastic immobilization masks used for head-and-neck cancer patients allow more 
movement of the head in the S-I dimension than in the other two dimensions. Of course the 
reason for the larger population random error for prostate cancer patients is due to the 
larger geometric variability of the target volume caused by internal organ motion, rectum 
and bladder filling and other factors previously discussed. 
.
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3.5.2 Comparison of error calculations for the different imaging techniques 
 
In order to determine whether the individual imaging modalities had an impact on these 
results, the population systematic errors (M), variation of population systematic errors (∑Ϳ 
and population random errors (σ) using the alignment data acquired with each of the 
different imaging modalities separately, were calculated. The results of this calculation are 
shown in Table 23 for head-and-neck cancer patients and in Table 24 for prostate cancer 
patients. 
Table 23: population systematic setup error (M), variation of population systematic error (∑Ϳ and 
population random error (σ) for the different imaging modalities – head-and-neck cancer patients 
IMAGING 
MODALITY 
 population systematic setup 
error (M) (cm) 
variaton of population 
systematic error ;∑Ϳ ;cŵͿ 
populatioŶ raŶdoŵ error ;σͿ 
(cm) 
S-I L-R A-P S-I L-R A-P S-I L-R A-P 
6MV -0.01 0.04 -0.03 0.15 0.16 0.14 0.16 0.15 0.13 
IBL 0.04 0.08 -0.03 0.13 0.11 0.14 0.21 0.18 0.18 
kV 0.06 0.05 -0.03 0.23 0.18 0.15 0.12 0.11 0.13 
 
 
IMAGING 
MODALITY 
 population systematic 
setup error (M) (cm) 
variaton of population 
systeŵatic error ;∑Ϳ ;cŵͿ 
population random error 
;σͿ ;cŵͿ 
S-I L-R A-P S-I L-R A-P S-I L-R A-P 
Planar imaging 0.03 0.07 -0.03 0.11 0.11 0.10 0.22 0.19 0.19 
CBCT 0.05 0.03 0.01 0.15 0.16 0.15 0.14 0.14 0.15 
IMAGING 
MODALITY 
 population systematic 
setup error (M) (cm) 
variaton of population 
systeŵatic error ;∑Ϳ ;cŵͿ 
population random error 
;σͿ ;cŵͿ 
S-I L-R A-P S-I L-R A-P S-I L-R A-P 
6MV Planar imaging 0.00 0.03 -0.02 0.15 0.15 0.12 0.16 0.15 0.14 
6MV CBCT -0.01 -0.09 -0.07 0.17 0.19 0.22 0.07 0.07 0.08 
IBL Planar imaging 0.06 0.08 -0.03 0.14 0.13 0.13 0.22 0.18 0.18 
IBL CBCT 0.02 0.04 0.01 0.16 0.16 0.21 0.11 0.12 0.10 
kV Planar imaging -0.03 0.04 -0.11 0.18 0.12 0.14 0.11 0.09 0.09 
kV CBCT 0.14 0.04 0.03 0.25 0.21 021 0.07 0.09 0.07 
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Table 24: population systematic setup error (M), variation of population systematic error (∑Ϳ and 
population random error (σ) for the different imaging modalities – prostate cancer patients 
IMAGING 
MODALITY 
 population systematic setup 
error (M) (cm) 
variaton of population 
systeŵatic error ;∑Ϳ ;cŵͿ 
populatioŶ raŶdoŵ error ;σͿ 
(cm) 
S-I L-R A-P S-I L-R A-P S-I L-R A-P 
6MV -0.08 -0.13 -0.06 0.19 0.24 0.22 0.34 0.34 0.21 
IBL -0.03 -0.01 -0.02 0.25 0.40 0.21 0.28 0.42 0.36 
kV 0.09 -0.09 -0.02 0.20 0.29 0.22 0.29 0.40 0.20 
 
 
 
IMAGING MODALITY 
 population systematic 
setup error (M) 
variaton of population 
systeŵatic error ;∑Ϳ 
population random error 
;σͿ ;ŵŵͿ 
S-I L-R A-P S-I L-R A-P S-I L-R A-P 
Planar imaging 
-0.02 -0.02 -0.04 0.17 0.20 0.17 0.33 0.43 0.24 
CBCT 
-0.03 -0.10 -0.02 0.28 0.38 0.27 0.38 0.50 0.39 
IMAGING MODALITY 
 population systematic 
setup error (M) (cm) 
variaton of population 
systeŵatic error ;∑Ϳ ;cŵͿ 
population random error 
;σͿ ;cŵͿ 
S-I L-R A-P S-I L-R A-P S-I L-R A-P 
6MV Planar imaging -0.09 -0.12 -0.09 0.19 0.25 0.28 0.30 0.35 0.19 
6MV CBCT -0.03 -0.15 -0.09 0.38 0.34 0.30 0.28 0.28 0.13 
IBL Planar imaging -0.01 0.01 -0.03 0.22 0.44 0.19 0.24 0.38 0.22 
IBL CBCT -0.06 -0.05 -0.01 0.37 0.33 0.27 0.32 0.45 0.46 
kV Planar imaging 0.09 -0.04 -0.05 0.21 0.29 0.24 0.28 0.30 0.21 
kV CBCT 0.09 -0.19 0.07 0.24 0.70 0.20 0.30 0.28 0.17 
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Discussion and conclusion(3.5.2) 
 
The population systematic error (M) calculated with different imaging techniques 
These results show that in terms of calculating the systematic error for both populations the 
different imaging modalities applied offer very similar results. The systematic error is always 
close to zero, no matter which imaging modality was used.  
 
Comparing errors calculated with 6MV, IBL and KV imaging 
Within the groups of head-and-neck cancer patients the variation of the population 
systematic errors (∑) is found to be slightly larger with the alignment data obtained from kV 
imaging, with values of 0.23 cm (S-I), 0.18 cm (L-R) and 0.15 cm (A-P) in comparison to the 
values obtained from 6MV and IBL alignment data, which range between 0.11 cm to 0.16 cm 
for all three directions. For prostate cancer patients we find different results for the variation 
of population systematic errors (∑Ϳ calculated with 6MV, IBL and kV alignment data 
separately.  In correspondence to the results calculated with all imaging modalities together 
the values are a lot larger for prostate cancer patients as opposed to head-and-neck cancer 
patients. The results for the L-R direction are notably larger in comparison to the S-I and A-P 
direction for all three imaging modalities. With 0.40 cm, the variation of population 
systematic error (∑Ϳ for the L-R direction determined with IBL imaging is considerably larger 
than the rest. This is followed by 0.29 cm with KV and 0.24 cm with 6MV imaging. IBL also 
offers the largest variation of population systematic errors (∑Ϳ for the S-I dimension, where it 
is 0.25 cm in comparison to 0.19 cm for 6MV and 0.20 cm for kV.  
Comparing the values for the population random errors (σ) determined with the different 
imaging energies for head and neck cancer patients, the largest variation can be found in the 
S-I dimension with values ranging from 0.12 for kV imaging, to 0.16 cm for 6MV imaging and 
0.21 cm for IBL imaging. The largest population random error (σ) can be found in the results 
of the alignment data obtained with IBL imaging (0.21 cm for S-I, 0.18 cm for L-R and A-P). 
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The smallest population random error (σ) is found with the results of the alignment data 
obtained with kV imaging (0.12 cm for S-I, 0.11 cm for L-R and 0.13 cm for A-P).  These 
results are similar to the results found within the population of head-and-neck cancer 
patient. Here for the L-R and the A-P direction IBL imaging leads to the largest population 
random error (σ) with values of 0.42 cm for L-R and 0.36 cm for A-P. However, for the S-I 
direction, IBL imaging leads to the smallest population random error (σ) with 0.28 cm in 
comparison to 0.34 cm for 6MV and 0.29 cm for kV. For kV imaging there is a great 
difference of the population random error (σ) evaluated for the three dimensions. For 
example, in the A-P direction the population random error (σ) is as little as 0.20 cm in 
comparison to 0.29 cm for  S-I and as much as 0.40 cm for the L-R direction.  
 
Comparing errors calculated with planar imaging versus CBCT imaging 
Our results comparing the variation of population systematic error (∑Ϳ for head-and-neck 
cancer patients determined with the alignment data obtained from planar, versus the 
alignment data obtained from CBCT imaging show that the values are smaller for planar 
imaging. For planar imaging the values are 0.11 cm for the S-I and the L-R direction and 0.10 
cm for the A-P direction. For CBCT imaging the values are 0.15 cm for the S-I and A-P 
direction and 0.16 cm for the L-R direction. This is consistent with our results for the 
population of prostate cancer patients. The variation of population systematic error (∑Ϳ 
calculated with planar imaging is 0.17 cm for the S-I and A-P direction and 0.20 cm for the L-
R direction. For CBCT the results are considerably larger for all three dimensions with values 
of 0.28 cm for S-I, 0.38 cm for L-R and 0.27 cm for A-P.  These results, therefore, show that 
for both patient populations three dimensional CBCT imaging leads to larger values for the 
variation of population systematic error (∑Ϳ. For the population random errors (σ) 
determined with the two different imaging techniques it is the opposite way. Three 
dimensional CBCT imaging is shown to lead to smaller population random errors (σ), in 
comparison to planar imaging. For head-and-neck cancer patients the results for CBCT are 
0.14 cm (S-I and L-R) and 0.15 (A-P) in comparison to planar imaging with 0.22 cm (S-I) and 
0.19 cm (L-R and A-P). For prostate cancer patients the calculated values for CBCT are 0.38 
cm (S-I), 0.50 cm (L-R) and 0.39 cm (A-P), in comparison to planar imaging with 0.33 cm (S-I), 
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0.43 cm (L-R) and 0.24 cm (A-P).  The results show that for both imaging techniques the L-R 
dimension offers the largest population random errors (σ). An interpretation for this might 
be that perhaps patient positioning is more reproducible when using CBCT imaging than 
when using planar imaging.  
 
Comparing the different errors calculated with all six different imaging techniques 
Our analysis of the variation of population systematic error (∑Ϳ and the population random 
error (σ) obtained with the alignment data of each of the six different imaging techniques 
available (the three different energies 6MV, IBL and kV each subdivided into planar imaging 
and CBCT imaging) shows that for head-and-neck cancer patients the largest variation of 
population systematic error (∑Ϳ can be found with kV CBCT imaging, the imaging offering the 
highest soft tissue contrast available (0.25 cm for S-I, 0.21 for L-R  and 0.21 for A-P). The 
smallest variation of population systematic error (∑Ϳ values is found with IBL planar imaging 
(0.14 cm for S-I, 0.13 cm for L-R and 0.13 cm for A-P) 
For the population of prostate cancer patients, the results for the variation of population 
systematic error (∑Ϳ obtained with the different imaging techniques show a much wider 
variation.  The highest value can be found with kV CBCT imaging with a value for the 
variation of population systematic error (∑Ϳ of 0.70 cm for L-R. The smallest values are found 
for 6MV planar imaging in the S-I dimension (0.19 cm) and kV planar imaging in the A-P 
direction (0.19 cm).  For the population random error (σ), evaluated with the different 
imaging techniques, these results show the smallest values for head-and-neck cancer 
patients for the 6MV CBCT and KV CBCT imaging, with values ranging from 0.07 and 0.09 in 
all directions. For prostate cancer patients there is again a large variation within the values 
evaluated with the alignment data different imaging techniques. Results range from 0.13 cm 
for 6MV CBCT in A-P to 0.45 cm for IBL CBCT in L-R.  
The large variation in these results may be due to the fact that the amount of the set-up 
verification images obtained with the different imaging techniques was too little. 
Additionally, there is a large variation within the amount of set-up images acquired with the 
different imaging techniques. In conclusion these results have shown that there are no clear 
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differences found in the calculation of set-up errors when using different imaging modalities. 
The detection of misalignment of the target volume appears to be independent from the 
imaging modality used for set-up verification imaging. The main limitation in this comparison 
is, that the set-up shifts compared are all from different treatment fractions. There is no 
direct comparison of the different imaging techniques within the same treatment fraction.  
Differences within the imaging modalities, therefore, may be due to different patient set-up 
on different treatment days. A comparison of all six different imaging techniques within the 
same treatment fraction would be beneficial, however, would excessively increase the 
imaging dose and is, therefore, not possible. Additionally, this would require more time 
during which shifts and changes of the patient position may occur. This retrospective study 
reflects the realistic clinical case in which imaging is performed at our institution. 
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3.6 Margin calculation applying the margin recipes by Stroom et al. (1999) 
and van Herk et al. (2000) 
 
After calculating the values for the variation of population systematic error (∑Ϳ and the 
population random error (σ) for both head-and-neck cancer patients and for prostate cancer 
patients the results were applied to the two margin recipes by Stroom et al. (1999): 
M=2∑+0.7σ and van Herk et al. (2000): M=2.5∑+0.7σ  introduced earlier. Table 25 shows the 
margins calculated for both patient populations and for all three directions (S-I, L-R and A-P). 
For head-and-neck cancer patients margins of 0.35 cm for the S-I direction and  0.33 cm for 
the L-R and A-P direction (according to Stroom et al., 1999) and margins of 0.4 cm for the S-I 
direction and 0.38 cm for the L-R and A-P direction (according to van Herk et al., 2000) were 
calculated. For prostate cancer patients the calculated margins are 0.57 cm, 0.70 cm and 
0.58 cm for the S-I, L-R and A-P direction (according to Stroom et al.,1999) and 0.66 cm, 0.79 
cm and 0.67 cm for the S-I, L-R and A-P direction (according to van Herk et al., 2000). 
 
Table 25: Observed set-up errors and calculated margins 
  
  
 population 
systematic  
setup error  
(M) (cm) 
variaton of 
population  
systematic error 
;∑Ϳ ;cŵͿ 
Population  
random 
 error  
;σͿ ;cŵͿ 
Margin calculation  
by Stroom et.al./van Herk 
2∑+0.7σ / 2.5∑+0.7σ 
(in cm) 
  
S-I L-R A-P S-I L-R A-P S-I L-R A-P S-I L-R A-P 
Head-and-neck 
cancer 
0.03 0.07 -0.03 0.10 0.10 0.10 0.22 0.19 0.19 0.35/0.4 0.33/0.38 0.33/0.38 
Prostate 
cancer 
-0.03 -0.05 -0.03 0.16 0.18 0.17 0.37 0.49 0.35 0.57/0.66 0.70/0.79 0.58/0.67 
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Discussion and conclusion (3.6) 
After application of the margin recipe our results reveal, that when planning the CTV-PTV 
margin for head-and-neck cancer patients, margins of 0.35 cm in the S-I direction, and of 
0.33 cm in the L-R and A-P directions are necessary according to Stroom et al. (1999) in order 
to account for set-up variation sufficiently.  According to van Herk et al. (2000) the margins 
need to be slightly larger in order to be adequate, with values of 0.4 cm in the S-I dimension 
and 0.38 cm in the L-R and A-P dimensions. As explained in methods and materials, at our 
department, margins between 0.5 cm and 1 cm are applied for head-and-neck cancer 
patients in order to account for geometrical uncertainties. For prostate cancer patients our 
results, after application of the margin recipe, have revealed margins in the size of 0.57 cm 
for S-I, 0.70 cm for L-R and 0.58 cm to be adequate according to Stroom et al. (1999) and 
again slightly larger according to van Herk et al. (2000) with 0.66 cm and 0.67 cm in the S-I 
and A-P dimension and 0.79 cm in the L-R dimension. In our clinic the PTV for radiation 
therapy of prostate cancer is usually created by adding a margin of approx. 1 cm to the CTV.  
These results, therefore, show that the CTV-PTV margins used at our institution are 
sufficient. According to the margin recipe presented by Stroom et al. (1999) and even 
according to the larger margins required by van Herk et al. (2000) our margins are found to 
successfully account for potential geometrical inaccuracies and set-up errors.  These results 
might be taken into consideration in future planning of radiation therapy for head-and-neck 
and prostate cancer patients at our clinic. For example a reduction of the CTV-PTV margin 
applied to head-and-neck cancer patients between 0.5 cm and 1 cm to a smaller margin 
between 0.4 cm and 0.5 cm for all directions might be possible. This would help sparing of 
the OAR’s aŶd other healthǇ tissue. AŶ iŶteresting result, revealed by our analysis, is that the 
margin required for prostate cancer in the L-R dimension is considerably larger (with at least 
0.70 cm) in comparison to the S-I (0.57 cm) and A-P (0.58 cm) dimensions. This means that 
for prostate cancer patients the variation of the position of the target volume varies more in 
the left-right direction than in the other two directions. This is interesting since factors 
affecting the position of the target volume, such as bladder and rectum filling should 
primarily affect the superior-inferior direction. The fact that the calculations of adequate 
CTV-PTV margins have resulted in larger margins for prostate cancer patients in comparison 
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to head-and-neck cancer patients is consistent to our previous results and, of course, due to 
the greater geometric variability of the target volume in prostate cancer patients.  
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4. Discussion 
 
Because of the substantial amount of different results this study has procured, a separate 
discussion was presented at the end of each chapter/section. In this chapter the previously 
discussed arguments are recapitulated and summarized. Additionally, further aspects that 
need to be taken into consideration when looking at the results of this study are elaborated. 
 
4.1 Recapitulation of previous discussion  
 
4.1.1 Employment of the different linacs 
The evaluation of the distribution of the two population groups included in this study 
showed that significantly more patients with prostate cancer (44%) were treated at the linac 
ART1, in comparison to head-and-neck cancer patients (31%). Out of the three linear 
accelerators available in our clinic the ART1, with the capability of kV imaging, offers the best 
imaging quality.  There are multiple factors that have an impact on the distribution of the 
patients to the different treatment machines and that influence the choice of the imaging 
modality used. The differences of the various anatomic sites need to be accounted for when 
choosing between treatment machines equipped with different technologies. Some target 
volume locations have higher rates of geometrical variations and uncertainties than others. 
For these target volumes better imaging techniques with a higher soft tissue contrast are 
required. This study demonstrates that this is taken into consideration when distributing the 
different patient populations to the individual treatment machines. The target volume in 
prostate cancer patients is subject to a much higher geometric variation, due to internal 
organ movement and differences in bladder and rectum filling, and therefore, in this case 
bony structures are not ideal as surrogates when aligning a patient on a treatment couch. To 
reduce set-up errors, high resolution imaging is necessary so that the target volume itself or 
other relevant anatomic structures can be visualized in the verification images. In 
comparison, head-and-neck tumors are fairly rigid in their anatomic position and patient 
  
 
 
 
 94  
 
alignment is much more reproducible, due to better immobilization devices such as the 
thermoplastic masks used. Therefore, when making a decision on the treatment machine 
that should be used for which patient, these differences need to be taken into consideration.  
The results of this study also demonstrated, that when using a treatment machine with 
͞ďetter͟ iŵagiŶg teĐhŶologǇ, the highest iŵagiŶg resolutioŶ aǀailaďle for the particular 
treatment machine was not always used. As shown in Figure 5, when treated with the ART1, 
as many as 26 % of the verification images for prostate cancer patients and more than half 
(58 %) of the verification images for head-and-neck cancer patients were IBL images. There 
are multiple reasons possible for this discrepancy in the utilization of the best imaging 
technique available and the imaging technique actually used.  Generally, the choice of the 
image guidance method used is at the discretion of the operating radiation therapist. 
However, certain protocols with predefined guidelines by the radiation oncologist are 
provided.  Possible reasons for these results may be found in the differences of work- and 
time-load. At the beginning of 2013 the time necessary to perform kV imaging was 
considerably larger in comparison to IBL imaging. This was due to the fact that in order to 
match the set-up verification images to the reference images time consuming gantry 
rotations of 180° were necessary. Also, for patients treated at the ART1 for the first time, 
new set-up fields need to be created in order to use kV imaging. Therefore, IBL imaging 
might have been preferred due to already existing set-up fields and time constraints. 
Additionally, as discussed earlier, the radiation therapists might have wrongly assumed that 
the dose of IBL planar imaging is similarly low in comparison to kV CBCT imaging and, 
therefore, for patients with a presumed lower geometric variation, such as head-and-neck 
cancer patients, IBL planar imaging was performed. The work of Ames (2015) and Dzierma et 
al. (2015), however, has demonstrated that this is not the case for head-and-neck imaging. 
AŶother possiďle reasoŶ for this result ŵaǇ siŵplǇ ďe the laĐk of eǆperieŶĐe ǁith the ͞Ŷeǁ͟ 
imaging device, resulting in a habitual preference for the familiar imaging technique. 
However, we expect that having been introduced in November 2012 kilovoltage imaging 
should have already been successfully incorporated in the daily routine by the beginning of 
2013, and indeed, as the results have shown, there is no time trend visible in the evaluation 
over the course of time. On an optimistic note, the radiation therapists in our clinic have 
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confirmed that today kV imaging is used much more frequently.  Wherever possible the SOP 
to always use the best imaging technique available at each treatment machine is followed. 
Furthermore, the time necessary for kV imaging has been decreased with the elimination of 
the 180° gantry rotation previously necessary for image matching.  
These results, however, have also demonstrated that the differences in anatomic sites and 
the differences in the complexity of the radiation technique used are taken into 
consideration when choosing treatment machines and imaging modalities. For example, for 
prostate cancer patients treated at the ART2, as many as half of the imaging is CBCT imaging. 
As discussed earlier, the ART2 was used exclusively for the IMRT fractions in prostate cancer 
treatment. IMRT is a much more complex radiation technique in comparison to 3DCRT. At 
the ONC2 and ART1 where 3DCRT prostate treatment was performed, the amount of CBCT 
imaging is distinctly smaller in comparison to planar imaging. When comparing the amount 
of three dimensional CBCT imaging for head-and-neck cancer patients and prostate cancer 
patients our results have demonstrated that prostate cancer patients received CBCT imaging 
much more frequently; also the amount of kV imaging is much higher for prostate cancer 
patients in comparison to head-and-neck cancer patients. As already largely discussed 
prostate cancer patients are much more prone to set-up errors due to a larger geometric 
variability of the target volume. Therefore, the results show that anatomic differences are 
taken into account when choosing the different imaging techniques.  
 
4.1.2 Employment of imaging modalities over the course of time 
Our expectation, that after introduction of a new imaging technique there would be a 
change in the employment of the different imaging modalities, was not confirmed. The 
amount of kV verification images varied from month to month for both populations. No 
image modality asserted itself as being superior to others for the different patient 
populations. In particular there was no visible increase in the amount of kV imaging obtained 
every month.  A possible reason for this might be that the evaluation time was not sufficient. 
However, as mentioned before, by the beginning of 2013, kV should have already been 
sufficiently established and fully integrated into the daily routine. Again, according to the 
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radiation therapists, kV imaging is now used much more frequently in the daily routine. 
Potentially a new evaluation in a few years covering a greater time span would have a 
different result regarding the employment of the different imaging modalities. 
 
4.1.3 Evaluation of the alignment data, systematic and random set-up errors 
The retrospective evaluation of the couch shifts, performed in order to correctly align the 
target volume to the position intended and defined during treatment planning, has shown 
very different results for the two populations included in this study. The range of couch 
shifts was found to be a lot larger for prostate cancer patients in comparison to head-and-
neck cancer patients. This is the case, not only for the range of all the individual couch shifts, 
but also for the mean set-up error for each individual patient. The calculations of the 
systematic and random set-up error for the entire populations have shown corresponding 
results. The variation of the systematic set-up error, as well as the random set-up error for 
the population of prostate cancer patients was found to be considerably larger in 
comparison to head-and-neck cancer patients. This result was to be expected since the 
variation of the position of the target volume is a lot larger in comparison to head-and-neck 
cancer patients, due to larger internal organ movement in prostate cancer patients and 
better immobilization methods for head-and-neck cancer patients.  
The systematic set-up error was close to zero for both patient populations and in all three 
directions. Therefore, these results have proven that there is no systematic error affecting all 
patients and all treatment fractions in the same way. This is a result that was expected and is 
proof of the efficiency of the quality assurance methods in our institution. 
Additionally, the results of this study have shown that the type of imaging technique used 
does not have a clear impact on the systematic and random set-up errors calculated. There 
were no clear differences found in the evaluation of the set-up errors using the alignment 
data obtained separately with the different imaging techniques.  
Although our results have proven that the geometric variability is generally larger for 
prostate cancer patients in comparison to head-and-neck cancer patients, with larger set-up 
errors found within the population of prostate cancer patients, our analysis of the range of 
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couch shifts found in individual sample patients for each population, has demonstrated that 
even within a certain patient population there are large differences in the geometric 
variability. This is due to the fact that the anatomic predisposition and factors influencing the 
reproducibility of the target volume are very different for individual patients in a patient 
population. This is an important aspect that needs to be taken into consideration in radiation 
therapy. Since it is not always clear which patients will have larger set-up errors than others, 
researchers have suggested performing multiple imaging during the first few treatment 
fractions in order to calculate systematic and random set-up errors for individual patients, 
and possibly adapt the treatment plan or perform more frequent imaging for patients with 
large set-up errors (Kupelian et al., 2008; Castadot et al., 2010). 
 
4.1.4 Margin calculation 
The calculations performed in order to calculate adequate CTV-PTV margins according to 
Stroom et al. (1999) and van Herk et al. (2000) have demonstrated that, generally, the 
margins which are currently used for head-and-neck cancer patients and prostate cancer 
patients are sufficient and ensure an adequate delivery of the radiation dosage to the target 
volume. As expected, the application of the margin recipes has resulted in larger margins for 
prostate cancer treatment in comparison to head-and-neck cancer treatment since set-up 
errors are larger for prostate cancer patients. Interesting, however, is the fact that the 
calculations have shown that the largest margin for prostate cancer patients is necessary in 
the L-R dimension, with approx. 0.8 cm in comparison to approx. 0.6 cm in the S-I and A-P 
dimension. For head-and-neck cancer patients the calculated margins are similar in all three 
dimensions with approx. 0.4 cm. 
Of course, the radiatioŶ oŶĐologists take the OAR’s aŶd other aŶatomic structures into 
account when defining the CTV. Therefore, the CTV-PTV margin is not always the same in all 
directions. For example, for prostate cancer patients margins near rectum and bladder and 
for head-and-neck cancer patient’s margins near the salivary glands or the brain are smaller 
than margins near anatomic structures with less importance. The results of our margin 
calculations could be taken into consideration in future treatment planning for head-and-
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neck cancer and prostate cancer treatment in our clinic and might help or influence the 
decision making of radiation oncologist during CTV definition in the treatment planning. The 
results might even be taken further. They could be used as guidelines to perform a margin 
reduction for the treatment planning of prostate and head-and-neck cancer patients. Our 
results have demonstrated that according to van Herk et al. (2000), in our institution, 
margins of 0.4 cm in all three directions should be sufficient for head-and-neck cancer 
patients and for prostate cancer patients margins of 0.7  cm for the S-I and A-P direction and 
margins slightly larger (0.8 cm) for the L-R direction should be sufficient. This could be 
discussed with the responsible radiation oncologists and possibly be applied in the future.  
 
4.1.5 Comparison to other studies 
Multiple studies have investigated the observed set-up errors by analyzing the alignment 
data of the preformed couch shifts after imaging and have calculated adequate CTV-PTV 
margins accordingly to these set-up errors. Table 26 shows a comparison of different studies. 
The random and systematic set-up errors observed in this study are generally consistent 
with previous studies.  In general, CTV-PTV ŵargiŶs ďased oŶ ǀaŶ Herk’s ŵargiŶ reĐipe 
where found to be in the order of 2.0-6.1 mm (3.8-4.0 mm in this study) for head-and-neck 
cancer patients and 3.5-13.4 mm (6.7-7.9 mm in this study) for prostate cancer patients. 
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Table 26: Overall systematic and random set-up errors (for all imaging modalities together) with 
corresponding PTV margins (in mm), compared with previous studies. Asterisk denotes values not 
given by the authors, but calculated here based on the set-up errors aŶd ŵargiŶ recipes. ᵻvalues 
are given for different anatomical landmarks used for image registration. 
 
Head-and-neck cancer patients 
 M (mm) ∑ ;ŵŵͿ σ (mm) margin 
(Stroom) 
(mm) 
margin (van Herk) 
(mm) 
 AP SI LR AP SI LR AP SI LR AP SI LR AP SI LR 
This study 0.3 0.7 0.3 1.0 1.0 1.0 2.2 1.9 1.9 3.5 3.3 3.3 4.0 3.8 3.8 
Suzuki
ᵻ
 -
0.1/ 
-0.8 
-
0.2/ 
0.8 
-
0.2/ 
-0.7 
0.8/ 
0.9 
1.2/ 
1.3 
0.9/ 
1.0 
0.6/ 
1.2 
0.9/ 
1.3 
0.7/ 
1.6 
2.7 3.0 3.3    
Polat -0.8 -0.5 0.0 1.6 1.3 1.6 1.6 1.4 2.1    5.1* 4.2 5.5 
Gupta    1.0 1.2 1.0 1.9 2.5 2.0 3.3 4.1 3.3 3.8 4.7 3.8 
Li 2DkV -0.2 0.1 0.1 0.5 0.6 0.6 1.2 1.2 0.7    2.1 2.3 2.0 
Li CBCT -1.1 0.1 0.2 1.6 1.5 1.3 1.6 1.6 1.2    5.1 4.9 4.1 
Pehlivan 0.9 1.2 0.9 1.8 2.3 1.9 3.9 5.0 4.2 3.1 4.0 3.1 3.6 4.6 3.6 
Wang -0.3 -0.7 -0.7 1.2 1.3 1.1 1.1 1.3 1.1    3.8 4.2 3.5 
Strbac    1.4 1.5 1.9 1.8 1.9 1.8 4.1 4.3 5.1 4.8 5.1 6.1 
Dionisi 0.5 0.9 -0.5 1.8 1.7 1.4 1.9 1.9 1.4    4.5 5.6 5.8 
 
Prostate cancer patients 
 M (mm) ∑ ;ŵŵͿ σ (mm) margin 
(Stroom) 
(mm) 
margin (van Herk) 
(mm) 
 AP SI LR AP SI LR AP SI LR AP SI LR AP SI LR 
This study 0.3 0.3 0.5 1.7 1.6 1.8 3.5 3.7 4.9 5.8 5.7 7.0 6.7 6.6 7.9 
Remeijer 0.9 -0.7 0.2 1.9 1.9 1.5 1.6 1.9 2.5    6.2* 6.1* 5.5* 
Nederveen -1.0 1.1 0.0 4.4 3.7 2.4 3.4 2.7 2.1    13.4* 11.1* 7.5* 
Poulsen    1.0 1.0  1.6 1.4     3.6 3.5  
Schallenkamp    2.5 1.9 2.0 3.5 2.0 1.6    7.3 5.1 5.0 
Osei 1.2 -0.8 -0.1 2.2 2.6 1.4 1.6 1.3 1.3    6.6* 7.4* 4.4* 
Graf (set-up) -1.2 0.1 0.8 2.4 2.1 1.6 2.7 2.7 2.3    7.9* 7.1* 5.6* 
Fox (set-up)    2.5 2.4 1.8 2.7 2.7 2.3    8.1* 7.9* 6.1* 
Huang -2.0 0.8 0.1 2.2 1.5 0.5 2.7 2.6 1.2    7.4 5.6 2.0 
Perks    2.6 1.6 2.2 2.4 1.9 3.5    8.2* 5.3* 8.0* 
Ost (set-up) -0.5 -1.1 1.5 2.6 1.8 2.7 1.8 1.2 1.9    7.7 5.4 8.0 
Mayyas 
(CBCT) 
-1.2 0.2 1.1 3.0 2.7 2.4 3.2 2.2 2.5    9.7 8.3 7.8 
Mayyas (kV) -2.9 -0.4 0.5 3.4 3.1 2.6 2.9 2.0 2.4    10.5 11.2 8.2 
Oehler 
(bones,CBCT) 
   1.9 1.7 0.6 1.9 1.7 0.9    6.1* 3.7* 2.1* 
Oehler 
(bones, kV) 
   1.8 1.4 0.8 2.0 2.3 0.9    5.9* 5.1* 2.6* 
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4.2 General aspects that have an impact on the results 
 
4.2.1 Workflow 
Another factor that needs to be taken into consideration when discussing these results is the 
general workflow, an aspect that should not be underestimated and has been previously 
discussed. When treating large numbers of patients every day, it is important that the 
workflow is efficient. In the daily clinical routine this has an impact on the distribution of the 
patients to the different treatment machines. There is no room for time delay; potential 
vacancies need to be filled; and the treatment machines need to be used in an efficient 
manner. Also manpower and organization is an important factor leading to the circumstance 
that all three treatment machines are not always in constant in use. The time necessary to 
obtain a CBCT image and to correct the corresponding set-up variations is much larger in 
comparison to that needed for two dimensional planar imaging. All these factors obviously 
have an effect not only on the distribution to the different treatment machines but also on 
the image modality chosen. 
 
4.2.2 Importance of education and training of health professionals 
For the practice of radiation therapy a coordinated multidisciplinary team consisting of 
radiation oncologists, medical physicists, radiation therapists, dosimetrists and planning 
experts, and other professionals is necessary.  Each professional group has its own field of 
expertizes. However, IGRT has led to significant changes in the practice of radiation therapy. 
With the introduction of new imaging techniques, new challenges for the different health 
care professionals have emerged and the roles of the different professionals have evolved 
accordingly. Adequate education and training of health professionals has become essential 
as new devices requiring specialized knowledge and skills are introduced. 
Especially the role of the radiation therapists professional has considerably changed with the 
new IGRT technologies.  Specialized knowledge when operating volumetric imaging devices 
is necessary.  The radiation therapist hast to be familiar with the operation of the hardware 
and software, has to be able to acquire good quality images and must be aware of the dose 
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associated with the imaging. Even when following protocols, a radiation therapist needs to 
make individual decisions at the time of imaging and verification when performing online 
corrections. With IGRT the responsibility of radiation therapists has increased.  One of the 
major advantages of volumetric imaging is the ability to identify the soft-tissue anatomy. 
Therefore, the target volume itself can be identified rather than depending on surrogates, 
such as bony landmarks, for the target. Unfortunately, radiation therapists often are not 
accustomed to identifying soft-tissue anatomy on images. This limits the advantage 
volumetric imaging may have on systematic and random errors. In our institution the 
matching of a verification image mostly relays on matching it to bony landmarks. The 
potential of the volumetric imaging is, therefore, not fully exhausted. Consequently, it is 
important to train the radiation therapists in soft-tissue identification.  A suggested strategy 
is to first perform an alignment to bony anatomy and then perform the alignment to soft 
tissue, the soft tissue alignment being in a predefined tolerance, relative to the bony 
anatomy. 
Obviously, the radiation oncologist needs similar specialized knowledge, since the radiation 
oncologist is responsible for the protocols defining the imaging frequency and imaging 
technique. Also the radiation oncologist must be present for the delivery of the first 
treatment fraction for each patient and is required to supervise the procedure. With 
advanced radiation techniques such as conformal radiation therapy, the radiation oncologist 
needs to be aware of the impact different set-up errors may have on the dose distribution. 
For example, the importance of correct target delineation during treatment planning is 
crucial for the success of the radiation therapy. The radiation oncologist must be aware of 
the different factors affecting the errors introduced through target delineation, such as 
inter- and intra-observer variability. Therefore, training knowledge on systematic- and 
random errors, inter-and intra-observer errors, both at the target delineation and image 
registration stage is advised (White E et al., 2007). 
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4.2.3 Reducing errors: Imaging frequency and adaptive radiotherapy 
The frequency of the verification images realized for the patients in our study was 
individually defined prior to treatment for each patient. In general, set-up verification 
images were obtained about twice a week. The fact that the number and frequency of 
verification imaging is different for each patient has an impact on our results. There are 
different protocols presented in the literature concerning the ideal frequency for imaging 
(e.g. Kupelian et al., 2008). With verification imaging and online correction preformed on a 
daily basis, the systematic and random errors could be minimized. However, this would 
considerably increase the radiation dose delivered to the patient and is very time 
consuming. For this reason studies have investigated the feasibility of using the couch shift 
measurements from several of the initial verification images to estimate and correct the 
presumed systematic error. Zumsteg et al. found that for head-and-neck cancer patients 
with large 3D correction vectors (> 5 mm) using the first five CBCT image guided 
measurements as an estimation, improved the daily set-up accuracy. However, for patients 
presenting large random errors, daily imaging might be necessary (Zumsteg et al., 2012). This 
is in agreement to a study by Zeidan et al. showing that imaging protocols with less than 
daily imaging do not eliminate random error but can effectively reduce systematic errors. 
The study by Zeidan et al. revealed that, even if every other treatment is image guided, 
about 11% of all treatments are still subject to three-dimensional (3D) set-up errors of at 
least 5 mm for head-and-neck cancer from random error, which demonstrated the necessity 
of daily imaging in addition to reliable immobilization (Zeidan et. al., 2007). 
When establishing a treatment plan for an individual patient, the plan is usually based on the 
imaging performed during treatment planning; in most cases this is the planning CT. This 
treatment plan, however, does not account for potential changes in the anatomy and 
position of the target volume occurring throughout the course of the radiation treatment. 
Reasons for changes are multiple, including decreasing tumor volume, weight loss and 
alteration in muscle mass and fat distribution. The anatomic changes over the course of the 
treatment have been proven to be especially large with treatment of head-and-neck cancer 
patients and have a potential dosimetric impact (Barker JL, 2004). With adaptive 
radiotherapy a concept to compensate these uncertainties and reduce dosimetric errors is 
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presented. It consists in re-planning and adapting the treatment plan throughout the course 
of radiation based on verification imaging realized during the course of treatment. It, 
therefore, takes into account the anatomic changes occurring. The procedure is very 
complex and time consuming and further investigation and research is necessary, such as 
realizing practical guidelines for identifying patients that would profit most from this 
adaptive treatment, calculating adequate CTV-PTV margins and research on the dose 
accumulation due to frequent imaging (Castadot et al., 2010). In a comparison of various 
online IGRT strategies investigating the benefits of plan re-optimization Schulze et al. found 
that for prostate cancer patients online treatment plan re-optimization may reduce the PTV 
margin, although for low risk patients, with only the prostate involved, online target 
alignment IMRT treatment would achieve similar results (Schulze et al., 2009).  
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5. Conclusion 
 
From the results of this retrospective study several different conclusions may be drawn:  
The analysis of the employment of the different treatment machines and imaging modalities 
has shown that the anatomic differences of target volumes in different patient populations 
is taken into account when making decisions on the distribution to the different lincas and 
when choosing the different imaging techniques used. This study has shown that, generally, 
better imaging techniques are used for IGRT for patients with larger expected set-up errors. 
However, the study has also revealed that especially at the linac ART1 there is still room for 
improvement since the best imaging technique was used not always in each situation. On a 
positive note, the radiation therapists have confirmed that the frequency of kilovoltage 
imaging has increased further and that currently in most situations the general work SOP to 
always use the best imaging technique available is pursued.  
Furthermore, this study has shown that the target volume in prostate cancer patients is 
subject to considerably greater geometric variability in comparison to that of the head-and-
neck cancer patients. The analysis of the alignment data for both populations has revealed 
that the couch shifts carried out to correctly position prostate cancer patients are larger by a 
factor of 1,5-2 in comparison to head-and-neck cancer patients. In addition, the calculation 
of set-up errors from the alignment data has shown that random population set-up errors 
are larger for prostate cancer in comparison to head-and-neck cancer patients. Another 
satisfactory result our study has procured is that for both patient populations there is 
practically no systematic set-up error. Therefore, the quality assurance measures in our clinic 
are shown to be successful. Additionally, this study has revealed that the choice of imaging 
modality used for IGRT does not have a clear effect on the calculation of set-up errors. 
Another conclusion that can be drawn from this study is that the CTV-PTV margins applied in 
our clinic for prostate and head-and-neck cancer patients are sufficient according to the 
margin recipes by van Herk et al. (2000) and Stroom et al. (1999). This shows that the 
margins currently used in our clinic ensure that the target volume is adequately treated. 
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Based on these results one might even consider a margin reduction for future treatment 
planning. In conclusion, it is also important to state that (as shown in this study) the 
geometric variability of target volumes, even within a certain patient population, may be 
very different for individual patients. Some patients are prone to greater set-errors in 
comparison to other patients. This needs to be taken into consideration when performing 
IGRT. For these patients the concept of adaptive re-planning or more frequent imaging 
might be beneficial. More research is necessary, especially in the areas of adaptive re-
planning, in order to establish treatment protocols that account for these great differences 
in the anatomy of individual patients. Also, as already mentioned in the discussion chapter, 
education of health professionals is essential in order to successfully deliver IGRT and to 
maximize its benefits. 
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IGRT Image-guided radiotherapy 
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